<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_RckAeCt">Comparative Effectiveness of an Automated Text Messaging Service for Monitoring COVID-19 at Home</title>
				<funder ref="#_4NDg98U">
					<orgName type="full">National Institutes of Health</orgName>
					<orgName type="abbreviated">NIH</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100000002</idno>
				</funder>
				<funder ref="#_Mc2CgeK">
					<orgName type="full">Patient-Centered Outcomes Research Institute</orgName>
					<orgName type="abbreviated">PCORI</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100006093</idno>
				</funder>
				<funder ref="#_yQbFf8u">
					<orgName type="full">Abramson Family Foundation</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD, MS</roleName><forename type="first">M</forename><forename type="middle">Kit</forename><surname>Delgado</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, MSc</roleName><forename type="first">Anna</forename><forename type="middle">U</forename><surname>Morgan</surname></persName>
						</author>
						<author>
							<persName><roleName>MSHP</roleName><forename type="first">David</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, MBA</roleName><forename type="first">Ruiying</forename><surname>Xiong</surname></persName>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Austin</forename><forename type="middle">S</forename><surname>Kilaru</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, MSHP</roleName><forename type="first">Kathleen</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">David</forename><surname>Do</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ari</forename><forename type="middle">B</forename><surname>Friedman</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Zachary</forename><forename type="middle">F</forename><surname>Meisel</surname></persName>
						</author>
						<author>
							<persName><roleName>MSHP</roleName><forename type="first">Christopher</forename><forename type="middle">K</forename><surname>Snider</surname></persName>
						</author>
						<author>
							<persName><roleName>MPH</roleName><forename type="first">Doreen</forename><surname>Lam</surname></persName>
						</author>
						<author>
							<persName><roleName>BA</roleName><forename type="first">Andrew</forename><surname>Parambath</surname></persName>
						</author>
						<author>
							<persName><roleName>BA</roleName><forename type="first">Christian</forename><surname>Wood</surname></persName>
						</author>
						<author>
							<persName><roleName>BA</roleName><forename type="first">Chidinma</forename><forename type="middle">M</forename><surname>Wilson</surname></persName>
						</author>
						<author>
							<persName><roleName>BS</roleName><forename type="first">Michael</forename><surname>Perez</surname></persName>
						</author>
						<author>
							<persName><roleName>BS, BA</roleName><forename type="first">Deena</forename><forename type="middle">L</forename><surname>Chisholm</surname></persName>
						</author>
						<author>
							<persName><roleName>MPH</roleName><forename type="first">Sheila</forename><surname>Kelly</surname></persName>
						</author>
						<author>
							<persName><roleName>MPH</roleName><forename type="first">Christina</forename><forename type="middle">J</forename><surname>O'malley</surname></persName>
						</author>
						<author>
							<persName><roleName>MHA</roleName><forename type="first">Nancy</forename><surname>Mannion</surname></persName>
						</author>
						<author>
							<persName><roleName>DNP, RN, CEN</roleName><forename type="first">Ann</forename><forename type="middle">Marie</forename><surname>Huffenberger</surname></persName>
						</author>
						<author>
							<persName><roleName>DBA, RN, NEA-BC</roleName><forename type="first">Susan</forename><surname>Mcginley</surname></persName>
						</author>
						<author>
							<persName><roleName>CRNP</roleName><forename type="first">Mohan</forename><surname>Balachandran</surname></persName>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Neda</forename><surname>Khan</surname></persName>
						</author>
						<author>
							<persName><roleName>BS</roleName><forename type="first">Nandita</forename><surname>Mitra</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Krisda</forename><forename type="middle">H</forename><surname>Chaiyachati</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<note type="raw_affiliation">Research Institute. and Center for Health Care Innovation , University of Pennsylvania Health System , Philadelphia , Pennsylvania (D.D.) ;</note>
								<orgName type="department">Center for Health Care Innovation</orgName>
								<orgName type="institution" key="instit1">Research Institute</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania Health System</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>Pennsylvania (D.D</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation">Center for Health Care Innovation , University of Pennsylvania Health System , Philadelphia , Pennsylvania</note>
								<orgName type="department">Center for Health Care Innovation</orgName>
								<orgName type="institution">University of Pennsylvania Health System</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>Pennsylvania</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">Center for Emergency Care Policy and Research , Department of Emergency Medicine , Perelman School of Medicine , University of Pennsylvania , Philadelphia , Pennsylvania</note>
								<orgName type="department" key="dep1">Center for Emergency Care Policy and Research</orgName>
								<orgName type="department" key="dep2">Department of Emergency Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>Pennsylvania</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">Division of General Internal Medicine , Department of Medicine , Perelman School of Medicine , University of Pennsylvania , Philadelphia , Pennsylvania (S.K.) ;</note>
								<orgName type="department" key="dep1">Division of General Internal Medicine</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>Pennsylvania (S.K</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<note type="raw_affiliation">Center for Connected Care , University of Pennsylvania Health System , Philadelphia , Pennsylvania</note>
								<orgName type="department">Center for Connected Care</orgName>
								<orgName type="institution">University of Pennsylvania Health System</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>Pennsylvania</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<note type="raw_affiliation">Department of Biostatistics, Epidemiology, and Informatics , Perelman School of Medicine , and Leonard Davis Institute of Health Economics , University of Pennsylvania , Philadelphia , Pennsylvania (N.M.) ; and</note>
								<orgName type="department" key="dep1">Department of Biostatistics, Epidemiology, and Informatics</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">Leonard Davis Institute of Health Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>Pennsylvania (N.M</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<note type="raw_affiliation">Division of General Internal Medicine , Department of Medicine , Perelman School of Medicine , Leonard Davis Institute of Health Economics , University of Pennsylvania , and Center for Health Care Innovation and Center for Connected Care , University of Pennsylvania Health System , Philadelphia , Pennsylvania</note>
								<orgName type="department" key="dep1">Division of General Internal Medicine</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep4">Center for Health Care Innovation and Center for Connected Care</orgName>
								<orgName type="institution" key="instit1">Leonard Davis Institute of Health Economics</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit3">University of Pennsylvania Health System</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>Pennsylvania</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_FMM2SNx">Comparative Effectiveness of an Automated Text Messaging Service for Monitoring COVID-19 at Home</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">B92CCB950D1CD94CD598AB19393BD743</idno>
					<idno type="DOI">10.7326/m21-2019</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T12:44+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords xml:id="_4PZrWHZ">Mid-Atlantic academic health system in the United States Patient-Centered Outcomes</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_2YBw8JA"><p xml:id="_9Vfg327"><s xml:id="_eZ5ffDQ">Background: Although most patients with SARS-CoV-2 infection can be safely managed at home, the need for hospitalization can arise suddenly.</s></p><p xml:id="_6Wvhem2"><s xml:id="_yjDW4DX">Objective: To determine whether enrollment in an automated remote monitoring service for community-dwelling adults with COVID-19 at home ("COVID Watch") was associated with improved mortality.</s></p><p xml:id="_vzrK3Gx"><s xml:id="_6avnECc">Design: Retrospective cohort analysis.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="612.0" lry="796.479"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_N68cKA4"><p xml:id="_UkWYTBN"><s xml:id="_yyPDGJq">A s of 24 August 2021, the United States is experiencing its fourth surge of SARS-CoV-2 (COVID-19) cases, averaging more than 153 000 cases per day, with several regions experiencing severe hospital-capacity strain <ref type="bibr" target="#b0">(1)</ref>.</s><s xml:id="_bMRSjwx">Nearly 90% of patients with COVID-19 are asked to self-isolate and monitor their symptoms at home <ref type="bibr" target="#b1">(2)</ref><ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref>.</s><s xml:id="_tpqBjFd">Remote outpatient monitoring of patients with COVID-19 has been needed because patients with SARS-CoV-2 infection can decline rapidly and unpredictably, and because of their own limited capacity to manage acute symptoms and concerns about staff safety, office-based outpatient practices often redirect patients with confirmed or suspected COVID-19 to hospitals.</s><s xml:id="_jX8dG6t">As a result, emergency departments (EDs) and hospitals have been overwhelmed during surge periods of high community incidence rates and prevalence <ref type="bibr" target="#b5">(6,</ref><ref type="bibr" target="#b6">7)</ref>.</s><s xml:id="_xGUH9xZ">However, patients with COVID-19 whose symptoms are worsening at home may delay or face delays in seeking care <ref type="bibr" target="#b7">(8)</ref><ref type="bibr" target="#b8">(9)</ref><ref type="bibr" target="#b9">(10)</ref>.</s><s xml:id="_JAPnQKs">Remote monitoring has the potential to facilitate ED-and hospital-level care for patients who require it while supporting access to care for patients who can safely remain at home <ref type="bibr" target="#b10">(11)</ref><ref type="bibr" target="#b11">(12)</ref><ref type="bibr" target="#b12">(13)</ref>.</s></p><p xml:id="_qWkZKSC"><s xml:id="_cEQmBJM">Toward those goals, the University of Pennsylvania Health System (Penn Medicine) developed COVID Watch, an automated text message-based, remote monitoring program with 24/7 clinical support <ref type="bibr" target="#b11">(12)</ref>.</s><s xml:id="_ux48hrj">This study compares outcomes for patients enrolled in COVID Watch with those of patients who were eligible to enroll but received usual care, with the hypothesis that enrollment in COVID Watch was associated with reduced mortality.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AP8A4pp">METHODS</head><p xml:id="_kYdJC8b"><s xml:id="_beC9RyU">This is a retrospective cohort study that follows the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guideline for reporting observational studies.</s><s xml:id="_hh96ybd">It was approved by the Institutional Review Board at the University of Pennsylvania.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EEgR9SE">Setting</head><p xml:id="_Dx5nhdf"><s xml:id="_568sPXc">Penn Medicine is an academic health system serving large portions of southeast Pennsylvania, New Jersey, and Delaware, with 6 hospitals and hundreds of outpatient practices.</s></p><p xml:id="_dMAFbYG"><s xml:id="_y9uWTXs">Community-dwelling adults (aged &gt;18 years) with presumed or confirmed COVID-19 could be enrolled in COVID Watch through an electronic health record order.</s><s xml:id="_8nzu9w2">The health care worker entering the electronic order did not have to be a physician and could include nurses, social workers, and care coordinators involved in the patient's care in the health system.</s><s xml:id="_5qteyE5">Enrollment often occurred during or after a provider had a conversation with a patient.</s><s xml:id="_EeAwk6d">Patients were not required to have established care with a Penn Medicine provider, having only received COVID-19 testing at Penn Medicine, for example.</s><s xml:id="_b5RYcGg">The design of COVID Watch is detailed elsewhere <ref type="bibr" target="#b11">(12)</ref> and in Supplement Figures <ref type="figure">1</ref> and <ref type="figure">2</ref> (available at Annals.org).</s><s xml:id="_Xs5zXvj">The first patient was enrolled on 23 March 2020.</s></p><p xml:id="_XRYEcm4"><s xml:id="_utzxsSx">The enrollment order results in an instantaneous text message sent to the patient introducing them to the program.</s><s xml:id="_hdNyNtM">Once enrolled and the patient texts back confirming they want to engage with the program, they begin receiving twice-daily automated text message check-ins asking the following question: "How are you feeling compared to 12 hours ago: better, same, or worse?"</s><s xml:id="_cVxm3VZ">Patients replying "worse" receive a follow-up question: "Is it harder than usual for you to breath: yes or no?"</s><s xml:id="_7D76ZxB">For patients who respond "yes," an alert is generated for a telemedicine clinician to contact the patient by telephone within 1 hour.</s><s xml:id="_2bRgfSU">Outside of the twice-daily check-ins, patients were instructed to text "worse" to trigger a clinician call back.</s><s xml:id="_9kESmB2">During the daytime, nurses were the primary responders, with support from nurse practitioners and physicians.</s><s xml:id="_P7FuJxE">At night, escalations were directly relayed to on-call nurse practitioners and physicians.</s></p><p xml:id="_uRFCd92"><s xml:id="_TcV9WQC">The clinical team for COVID Watch received regular training and guidelines for managing patients with COVID-19.</s><s xml:id="_P936ShZ">After an escalation, clinicians could provide reassurance, advise how best to manage symptoms at home, prescribe medications, or redirect patients to the ED.</s><s xml:id="_kZUxB9E">The program continued for 14 days from enrollment, at which point patients were offered the option to remain enrolled for 7 more days.</s><s xml:id="_7nm4zWt">A Spanish-language version of COVID Watch was made available on 18 May 2020.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jBG3tQP">Data Sources and Study Sample</head><p xml:id="_SVU6aQM"><s xml:id="_Msstwu6">We included all community-dwelling adults who tested positive for SARS-CoV-2 at Penn Medicine as outpatients between 23 March (the start of COVID Watch) and 30 November 2020 and determined if they were enrolled in COVID Watch versus usual care.</s><s xml:id="_EvPaXuk">We excluded patients who did not meet eligibility criteria for COVID Watch: those who were younger than 18 years, were actively enrolled in home health services or hospice, or were currently in long-term care (for example, skilled-nursing facility, long-term acute care, or acute rehabilitation).</s><s xml:id="_C4zAMAM">To further reduce the potential for bias, we excluded those who were tested in a location where COVID Watch enrollment had not yet begun, were previously in long-term care or hospice, or had a documented do not resuscitate or do not intubate code status before COVID-19 test collection.</s><s xml:id="_D2vhVGY">If patients had multiple positive test results for COVID-19, the first test with a positive result was chosen as the index test.</s><s xml:id="_vKPN4hy">We excluded patients enrolled in COVID Watch more than 7 days before or after the date of their index COVID-19 test collection to avoid attribution of outcomes to COVID Watch enrollment for other episodes of care (for example, repeated COVID-19 testing).</s></p><p xml:id="_D6qW5Mv"><s xml:id="_ExQJB6a">We derived patient-level sociodemographic and clinical characteristics from Penn Medicine's electronic health record.</s><s xml:id="_FqJn3ur">We derived patient death data, clinical encounter details (ED visits, hospitalizations, outpatient office visits, and telemedicine), and documented details (for example, encounter dates and in-hospital vs. out-of-hospital mortality) from Penn Medicine's electronic record and a regional health information exchange containing data from 53 surrounding hospitals in Pennsylvania, New Jersey, and Delaware <ref type="bibr" target="#b13">(14)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_WxjgBhp">Outcomes</head><p xml:id="_xXBYhAP"><s xml:id="_aU88Wq4">Outcomes were ascertained within 30 days of the date of COVID-19 test collection.</s><s xml:id="_KyJXZXv">We used an intention-to-treat approach in which any patient enrolled in COVID Watch was included in the COVID Watch group even if they did not respond to any text messages.</s><s xml:id="_brVaJgs">The primary outcome was any-site mortality.</s><s xml:id="_pqnmC6S">We separately analyzed deaths that occurred in hospital or out of hospital.</s><s xml:id="_xZbN5BE">Secondary outcomes included rates of total ED encounters (including discharges and hospitalizations), hospitalizations (inpatient admissions and observation), and outpatient encounters (in-person office visits and telemedicine, including video or telephone visits).</s><s xml:id="_ZEAS5PX">We tabulated a composite outcome of days alive and out of the hospital, which factors in death and the ability to remain out of the hospital by accounting for ED visits and, if hospitalized, the length of stay <ref type="bibr" target="#b14">(15)</ref><ref type="bibr" target="#b15">(16)</ref><ref type="bibr" target="#b16">(17)</ref><ref type="bibr" target="#b17">(18)</ref>.</s><s xml:id="_HQeB2eM">As a secondary analysis, we extended the follow-up window to 60 days for mortality and health care use measures.</s></p><p xml:id="_9B8JCm4"><s xml:id="_Me3GeUq">Among patients who required acute care, we tabulated the time from the collection of the positive result to ED presentation, the ED vital signs, the length of stay if hospitalized, and whether the patient needed intubation and mechanical ventilation.</s><s xml:id="_HhBKC4d">Finally, we tabulated process outcomes among those enrolled in COVID Watch, including how many text message check-ins they responded to, the proportion who triggered an escalation to the on-call nurse, and the triage recommendations of the on-call nurse.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_e94gMYW">Covariates</head><p xml:id="_FcsFsXY"><s xml:id="_GyGR4vu">We collected patients' COVID-19 test data, age, sex, race/ethnicity, primary insurance, county of residence, and household income derived from ZIP code median values.</s><s xml:id="_72RAn3X">We included comorbidities known to be associated with severe COVID-19 illness or treatment adherence <ref type="bibr" target="#b18">(19)</ref><ref type="bibr" target="#b19">(20)</ref><ref type="bibr" target="#b20">(21)</ref><ref type="bibr" target="#b21">(22)</ref><ref type="bibr" target="#b22">(23)</ref><ref type="bibr" target="#b23">(24)</ref>.</s><s xml:id="_h4pPnEe">We captured whether patients had a listed primary care provider and baseline health care use,</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dNeqCHr">Continued on following page</head><p xml:id="_UK52puA"><s xml:id="_dCJwbWM">Outcomes of Automated Home Monitoring for COVID-19</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6MYF3MP">ORIGINAL RESEARCH</head><p xml:id="_NhqBXtd"><s xml:id="_yYj63TK">including the frequency of encounters with Penn Medicine in the prior year-ED visits, hospitalizations, and outpatient encounters.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_UDSF6Wx">Statistical Analysis</head><p xml:id="_VQWWCRj"><s xml:id="_eeAy8qv">All extracted variables were checked for outliers and missingness.</s><s xml:id="_5j4sdVf">Only 21 patients of 7865 who met inclusion criteria (0.27%) were missing any covariate data and excluded from the primary analysis.</s><s xml:id="_QPpsDaU">To account for imbalances on covariates between comparison groups in the outpatient cohort, we estimated propensity scores (the probability of enrollment in COVID Watch) using logistic regression.</s><s xml:id="_5HQt4Ep">After using inverse probability of treatment weighting, we found that all covariates achieved balance between patients enrolled in COVID Watch and usual care with mean standardized differences of less than 0.1 <ref type="bibr" target="#b24">(25)</ref>.</s><s xml:id="_hghhmU7">Outcome models weighted by inverse probability of treatment weights were either logistic for binary outcomes or linear for continuous outcomes.</s><s xml:id="_ESyFvfH">We did a priori subgroup analyses of outcomes by race/ethnicity.</s></p><p xml:id="_ZKXS4NH"><s xml:id="_rYCDm9G">To assess the robustness of our findings, we assessed the sensitivity of our mortality results to potential unmeasured confounding by using the Rosenbaum g approach.</s><s xml:id="_x7YnyCW">We also tabulated any deaths that occurred in patients with missing covariates (n = 21).</s><s xml:id="_mKBX2w5">We also did a per protocol analysis, excluding any patients enrolled in COVID Watch who did not respond to any text messages, including the enrollment invitation text.</s><s xml:id="_qRP3pyK">Finally, we tabulated baseline characteristics and diagnoses of patients who died.</s><s xml:id="_KuGU3mj">All analyses were done using R, version 3.6.0</s><s xml:id="_AUWaXxJ">(R Project for Statistical Computing).</s><s xml:id="_6u3DWmW">All analyses used 2-sided statistical tests, and a P value less than 0.05 was considered statistically significant.</s><s xml:id="_RRgcfBp">Additional methodological details about the development of propensity scores can be found in the Supplement (available at Annals.org).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ujMRf49">Role of the Funding Source</head><p xml:id="_pdS7cTx"><s xml:id="_4eCzFa9">The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CfjQ34Z">RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FGQEKUC">Baseline Characteristics</head><p xml:id="_vaJFAmY"><s xml:id="_MpTzPHu">After ineligible patients (Appendix Figure, available at Annals.org) were excluded, 7865 outpatients were available for analysis: 3488 patients enrolled in COVID Watch and 4377 in usual care.</s><s xml:id="_bbPBmZm">Patients in COVID Watch were enrolled a mean of 1.8 days (SD, 2.3) after the date of COVID-19 test collection.</s><s xml:id="_nV4cTX3">Before propensity score weighting, patients enrolled in COVID Watch were similar to those who received usual care in age but were less likely to be male (37.1% vs. 42.5%)</s><s xml:id="_DgSUBfd">and were more likely to identify as non-Hispanic Black (47.9% vs. 32.1%),</s><s xml:id="_8XTg2sF">have public insurance (29.3% vs. 26.6%),</s><s xml:id="_VWT7Uzr">not have a primary care provider (28.3% vs. 24.5%),</s><s xml:id="_PuBydPY">have a higher mean body mass index (33.6 vs. 29.7 kg/m 2 ), have certain comorbidities (hypertension, diabetes, and asthma), have a lower median household income ($51 491 vs. $60 638), have higher rates of ED and office visits in the past year, and be enrolled in the earlier months of the pandemic (Table <ref type="table" target="#tab_0">1</ref>; Supplement Figure <ref type="figure">3</ref>, available at Annals.</s><s xml:id="_RyN95Sp">org).</s><s xml:id="_vc943pz">Covariates were well balanced after propensity score weighting (Table <ref type="table" target="#tab_2">2</ref>; Supplement Figure <ref type="figure">4</ref>, available at Annals.org).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AQ3gjdZ">Outcomes</head><p xml:id="_wc6TgxP"><s xml:id="_EGZ3Af9">Of the 3488 patients enrolled in COVID Watch, 3028 (86.8%) engaged by responding to at least 1 text (mean, 23 check-in responses).</s><s xml:id="_QtueSHy">Of patients who engaged, 434 (14.3%) triggered an escalation to a registered nurse, with mean response time of 24 minutes (Supplement Table <ref type="table" target="#tab_0">1</ref>, available at Annals.org).</s></p><p xml:id="_4dNsmrF"><s xml:id="_WTZwX4a">At 30 days, 3 of 3488 (0.09%) patients enrolled in COVID Watch died versus 12 of 4377 (0.27%) who received usual care (Table <ref type="table" target="#tab_4">3</ref>).</s><s xml:id="_6JnHyCt">Of the deaths, 0 in COVID Watch occurred outside the hospital versus 6 of those who received usual care.</s><s xml:id="_Jd6nBnF">Among in-hospital deaths, 2 of the 3 in COVID Watch occurred in hospitals outside of Penn Medicine compared with 5 of 6 in the usual care group.</s><s xml:id="_s6p9bwk">At 60 days, there were 2 additional in-hospital deaths among those enrolled in COVID Watch and 4 among those who received usual care.</s><s xml:id="_2pJtcUe">In total, 37.5% of the deaths at 60 days in the usual care group occurred outside the hospital.</s><s xml:id="_PqDtajJ">After propensity score weighting and modeling, at 30 days, those enrolled in COVID Watch had an odds ratio for overall mortality of 0.32 (95% CI, 0.12 to 0.72), with a difference of À1.8 deaths per 1000 patients (CI, À3.1 to À0.5) (P = 0.005).</s><s xml:id="_QpnS4Zu">At 60 days, COVID Watch outcomes remained consistently better, with a difference of À2.5 deaths per 1000 patients (CI, À4.0 to À0.9) (P = 0.002).</s><s xml:id="_UbxdxWw">Furthermore, we found that COVID Watch was associated with equitable treatment benefits, with White, Black, and Hispanic subgroups all having reduced mortality by 60 days (Table <ref type="table" target="#tab_4">3</ref>).</s></p><p xml:id="_FsPZydu"><s xml:id="_n8zuh8J">Within 30 days, COVID Watch patients had a total of 489 ED encounters (121 per 1000), with 384 (78.5%)</s><s xml:id="_yum28Gq">When ED and hospital use was factored in with mortality, the mean number of days alive and out of the hospital within 30 days was marginally lower among COVID Watch patients (adjusted absolute difference, À0.2 [CI, À0.3 to À0.1]; P &lt; 0.001) but was similar at 60 days (adjusted absolute difference, À0.1 [CI, À0.3 to 0.03]; P = 0.103) (Table <ref type="table" target="#tab_5">4</ref>) as deaths accrued and health care use diminished.</s></p><p xml:id="_Kaemser"><s xml:id="_WbYuwU4">Among patients who presented to any hospital (within Penn Medicine or outside) for the first time in the 30 days after their date of COVID-19 test collection (Table <ref type="table" target="#tab_5">4</ref>), COVID Watch patients presented to the ED sooner (6.6 vs. 8.9 days) (propensity score-weighted difference, À1.9 days [CI, À2.9 to À0.9 days]; P &lt; 0.001).</s></p><p xml:id="_99atkWW"><s xml:id="_rY5VtH5">Among the subset of patients who presented to the ED within Penn Medicine (Table <ref type="table" target="#tab_6">5</ref>), COVID Watch enrollees compared with usual care patients presented to the ED even sooner (6.1 vs. 9.0 days) (propensity scoreweighted difference, À2.9 days [CI, À4.1 to À1.7 days]; P &lt; 0.001).</s><s xml:id="_yPM732v">During the ED evaluation, there were no statistically significant differences in vital signs or need for intubation and ventilation.</s><s xml:id="_khmWvEu">However, compared with the 10.8% of usual care patients who received dexamethasone in Penn Medicine hospitals, the 11.3% of COVID Watch patients who were treated with dexamethasone received it sooner (propensity score-weighted difference, À3.0 days [CI, À5.6 to À0.4 days]; P = 0.026).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_WjpXsw5">Sensitivity Analyses</head><p xml:id="_NvDgbkb"><s xml:id="_3nanvhU">The Rosenbaum bounds analysis showed there would need to be 1.8 times greater odds of differential assignment to COVID Watch attributable to unobserved factors, a substantial amount of unmeasured confounding needed to reverse the statistically significant findings (Supplement Table <ref type="table" target="#tab_2">2</ref>, available at Annals.org).</s><s xml:id="_bQc2kxN">There were also no deaths among the 21 patients excluded from the outpatient cohort because of missing covariate data (Supplement Table <ref type="table" target="#tab_4">3</ref>, available at Annals.org).</s><s xml:id="_cP5ZvEq">We also found that 2 of the 5 deaths in COVID Watch occurred among the 13.2% of the patients who never engaged with the system.</s><s xml:id="_bFwCPbk">The per protocol analysis of patients who engaged with COVID Watch indicated even stronger treatment effects: odds ratio for death of 0.25 (CI, 0.10 to 0.55), with a difference of À2.8 deaths per 1000 patients (CI, À4.3 to À1.3 deaths) (P = 0.001) (Supplement Table <ref type="table" target="#tab_5">4</ref>, available at Annals.org).</s><s xml:id="_c3SGwbH">Finally, baseline characteristics of patients who died varied but were not statistically significant from each other across treatment groups (Supplement Table <ref type="table" target="#tab_6">5</ref>, available at Annals.org), and coded diagnoses of in-hospital deaths were consistent with COVID-19 being the primary cause of death (Supplement Table <ref type="table">6</ref>, available at Annals.org).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Xnk2mfb">DISCUSSION</head><p xml:id="_WfUAx7m"><s xml:id="_9h6XHn8">This study has 4 main findings.</s><s xml:id="_MNRu6c5">First, the mortality rate for community-dwelling adults with COVID-19 was significantly lower among those in COVID Watch compared with usual care, even after adjustment for differences in patients' clinical and sociodemographic characteristics.</s><s xml:id="_hrCZHFg">Second, more than one third of the deaths in the usual care group occurred outside the hospital versus none among those in COVID Watch.</s><s xml:id="_NYAXMBp">Third, patients in COVID Watch were more likely to present to the hospital, and they presented earlier.</s><s xml:id="_wSqPkRC">Fourth, all major racial and ethnic subgroups had reduced mortality rates when enrolled in COVID Watch.</s></p><p xml:id="_EhvcZWM"><s xml:id="_Hjbgx2k">These findings imply that COVID Watch is associated with a 64% relative reduction in the risk for death and that 1 life was saved for every 400 patients enrolled-or about 1 every 4 days during peak enrollment weeks.</s><s xml:id="_EfzhWzS">Although remote patient monitoring programs used to manage patients with COVID-19 outside of hospital settings have been described <ref type="bibr" target="#b25">(26,</ref><ref type="bibr" target="#b26">27)</ref>, including 1 study from Kaiser Permanente that reported unadjusted morality rates of 2.3% in usual care versus 1.3% with remote monitoring <ref type="bibr" target="#b27">(28)</ref>, we believe ours to be the first risk-adjusted study to show improved survival.</s></p><p xml:id="_YmDmpe6"><s xml:id="_sDz6hb3">Public health messaging strongly promoted staying home to promote social distancing and decrease hospital strain during the pandemic <ref type="bibr" target="#b28">(29,</ref><ref type="bibr" target="#b29">30)</ref>.</s><s xml:id="_VHedhPx">However, those</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SP3nhtu">ORIGINAL RESEARCH</head><p xml:id="_UmsUsby"><s xml:id="_vnkds4K">Outcomes of Automated Home Monitoring for COVID-19 messages were accompanied by decreases in emergent conditions presenting to the ED and increased out-of-hospital deaths <ref type="bibr" target="#b7">(8,</ref><ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b30">(31)</ref><ref type="bibr" target="#b31">(32)</ref><ref type="bibr" target="#b32">(33)</ref><ref type="bibr" target="#b33">(34)</ref><ref type="bibr" target="#b34">(35)</ref><ref type="bibr" target="#b35">(36)</ref><ref type="bibr" target="#b36">(37)</ref><ref type="bibr" target="#b37">(38)</ref><ref type="bibr" target="#b38">(39)</ref>.</s><s xml:id="_9tEA6Tc">In this study, 37.5% of deaths among patients who received usual care occurred outside the hospital versus none among patients in COVID Watch, which is consistent with the interpretation that COVID Watch exerts its effect by increasing vigilance over those at home and efficiently sorting them into those who will benefit from the ED and those who will not <ref type="bibr" target="#b7">(8,</ref><ref type="bibr" target="#b31">32)</ref>.</s><s xml:id="_ajw8CTc">Further evidence supports this mechanistic hypothesis.</s><s xml:id="_ayTCH2H">Patients in COVID Watch were more likely to present to the hospital and presented earlier, likely improving their ability to benefit from the care they receive.</s><s xml:id="_uxqumA8">For example, dexamethasone reduces mortality and length of stay for patients with COVID-19 <ref type="bibr" target="#b39">(40)</ref>, and the benefit may be larger if the drug is administered earlier in the disease course <ref type="bibr" target="#b40">(41)</ref><ref type="bibr" target="#b41">(42)</ref><ref type="bibr" target="#b42">(43)</ref><ref type="bibr" target="#b43">(44)</ref><ref type="bibr" target="#b44">(45)</ref>.</s><s xml:id="_pymkdRy">We found that among those who received dexamethasone in Penn Medicine hospitals, COVID Watch patients received the medication 3 days earlier on average.</s><s xml:id="_BkDftQ6">We also found that the treatment effects associated with COVID Watch were stronger among those who engaged with the remote monitoring service; 2 of the 5 deaths in the COVID Watch group were among the 13% of enrolled patients who never engaged the system.</s><s xml:id="_RD4KemK">The constellation of these findings is consistent with the view that COVID Watch operates as an early warning and referral system for communitydwelling patients <ref type="bibr" target="#b12">(13)</ref>.</s></p><p xml:id="_qXkqMnv"><s xml:id="_7S87WRT">The combination of technology-based, automated remote monitoring <ref type="bibr" target="#b45">(46)</ref> backed by clinician support may be necessary ingredients for the observed clinical effect.</s><s xml:id="_hum7NYy">Because COVID Watch was automated, only 2 to 4 staff members were required to oversee more than 1000 patients at a time, far fewer than personnel-intensive calling systems <ref type="bibr" target="#b25">(26,</ref><ref type="bibr" target="#b26">27)</ref>.</s><s xml:id="_XWcbYKc">Because it relied on symptom selfreport, COVID Watch did not require dedicated temperature sensors or pulse oximetry <ref type="bibr" target="#b11">(12,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b46">(47)</ref><ref type="bibr" target="#b47">(48)</ref><ref type="bibr" target="#b48">(49)</ref>.</s><s xml:id="_GNFx9R8">The use of additional equipment in the home varies substantially across remote patient monitoring programs, and its incremental value is unknown <ref type="bibr" target="#b49">(50)</ref>.</s><s xml:id="_R6vhkdf">Future research is needed to determine whether this type of monitoring service could be adapted to other acute conditions (for example, pneumonia or cellulitis) and chronic conditions (for example, asthma or diabetes) in which automated text check-ins and low barrier access to rapid clinical assessment and ED triage could improve outcomes.</s></p><p xml:id="_dpW4Ja7"><s xml:id="_KCMVFDE">In our study, non-Hispanic Black patients were more likely to be enrolled in COVID Watch than usual care,</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_WYSmcw7">ORIGINAL RESEARCH</head><p xml:id="_e5v96j5"><s xml:id="_4VCeCwe">and Hispanic patients were about as likely to be in either group.</s><s xml:id="_r84yg6A">White, Black, and Hispanic populations also had significantly reduced mortality when enrolled in COVID Watch, and the overall mortality rates were lower relative to reports nationally <ref type="bibr" target="#b27">(28,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b50">51,</ref><ref type="bibr" target="#b51">52)</ref>.</s><s xml:id="_qMqzSqd">These findings suggest no substantial racial or ethnic barriers to program enrollment or its effectiveness and that implementing this type of remote monitoring service has the potential to reduce racial disparities in regions in which Black and Hispanic patients have decreased access to care and higher mortality rates.</s></p><p xml:id="_6zAZca7"><s xml:id="_Va8Ju8y">This study has limitations.</s><s xml:id="_KgTF6af">First, we could observe deaths in our hospitals and hospitals outside our health system via a health information exchange linkage, but we may have incomplete ascertainment of out-of-hospital deaths.</s><s xml:id="_y2U8MUc">Death certificate linkage via the National Death Index was not available at the time of manuscript submission because of lag times in these databases.</s><s xml:id="_g5HhUX3">However, COVID Watch patients were highly engaged with Penn Medicine, replying to a mean of 23 text message checkins through the program, which suggests that their deaths would more likely be ascertained.</s><s xml:id="_5rMeDTT">‡ This is a composite metric that accounts for ED visits and, if hospitalized, the length of stay as well as days after death.</s><s xml:id="_6YZkHBJ">§ Telemedicine visits included video and telephone visits.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_46XCefe">ORIGINAL RESEARCH</head><p xml:id="_HKxYMRh"><s xml:id="_P9gm5vv">Outcomes of Automated Home Monitoring for COVID-19</s></p><p xml:id="_gxVcSsZ"><s xml:id="_7XQm5WW">Second, we cannot capture hospital use outside of the geography of health information exchange.</s><s xml:id="_B8bx9Ey">Fortunately, 99.4% of our study sample had residential ZIP codes within the geographic region covered by the health information exchange, decreasing the potential for incomplete capture of hospital use.</s></p><p xml:id="_n862jef"><s xml:id="_bGcEwVd">Third, we cannot capture the reasons patients were enrolled in COVID Watch or whether patients were verbally offered COVID Watch and declined it.</s><s xml:id="_vYjBWSp">We also cannot capture social needs, the nature and timing of symptoms before the testing date, and other unobserved confounders that may affect outcomes.</s><s xml:id="_9x8s7HX">However, higher rates of characteristics associated with worse outcomes from COVID-19 were seen in the COVID Watch group, including the lack of a primary care physician, Black race, residing in a lower-income ZIP code, greater body mass index, higher rates of high-risk comorbidities, and higher proportion treated early in the pandemic <ref type="bibr" target="#b5">(6,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b52">(53)</ref><ref type="bibr" target="#b53">(54)</ref><ref type="bibr" target="#b54">(55)</ref>, all suggesting higher expected mortality among the COVID Watch group.</s><s xml:id="_aRxXfRZ">Furthermore, our sensitivity analyses indicated there would need to be a 1.8 times greater odds of differential assignment to COVID Watch versus the control group that was attributable to unobserved factors.</s><s xml:id="_jVSZ74x">Given the large number of important covariates we have accounted for in our analysis, it is unlikely that such an impactful covariate was not included.</s></p><p xml:id="_abDHdNJ"><s xml:id="_DUu3T4v">Fourth, outcomes measured reflect care received at a single health system, a select set of hospitals in a specific region of the United States, which may limit generalizability of our findings.</s><s xml:id="_Be683n5">However, this study included populations with a diverse set of comorbidities and sociodemographic characteristics.</s><s xml:id="_Gurpb4D">Relatedly, we were unable to measure clinical status and treatments provided during hospital encounters outside our health system.</s><s xml:id="_EUBNKRc">Given the differential use of hospitals outside our health system, clinical treatment rates seen within our health system should not be extrapolated to the subset treated in hospitals outside our health system.</s></p><p xml:id="_JKxSNkc"><s xml:id="_eAnamSz">This study also has strengths.</s><s xml:id="_MsjQpre">It reflects what is, to our knowledge, the largest and most comprehensive sample and evaluation of a remote monitoring service for COVID-19 in the United States.</s><s xml:id="_CR3vUnq">There is careful adjustment for differences in patient characteristics that have a conservative bias.</s><s xml:id="_kxPsA62">The effect size is large, and the results are accompanied by plausible mechanisms whose specific elements are suggested by secondary analyses.</s></p><p xml:id="_9V6eDUY"><s xml:id="_rayKHTE">In conclusion, enrollment in an automated text messaging service among community-dwelling adults newly diagnosed with COVID-19 in outpatient settings was associated with reduced mortality, potentially explained by increased and earlier presentation to the ED by those benefiting from early interventions.</s><s xml:id="_mtd5SMy">These results reveal a model for outpatient health system management of patients with COVID-19 and possibly other conditions where the early detection of clinical declines is critical.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_D7gh2rS"><s xml:id="_vY2UQTd">Unadjusted Baseline Characteristics</s></p></div></figDesc><table><row><cell>Characteristic</cell><cell>Overall</cell><cell>COVID Watch Group</cell><cell>Usual Care Group</cell><cell>Standardized</cell></row><row><cell></cell><cell>(n = 7865)</cell><cell>(n = 3488)</cell><cell>(n = 4377)</cell><cell>Mean Difference*</cell></row><row><cell>Mean age (SD), y</cell><cell>43.4 (15.7)</cell><cell>43.5 (14.8)</cell><cell>43.3 (16.4)</cell><cell>0.013</cell></row><row><cell>Age group, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;40 y</cell><cell>3656 (46.5)</cell><cell>1585 (45.4)</cell><cell>2071 (47.3)</cell><cell>0.038</cell></row><row><cell>40-49 y</cell><cell>1472 (18.7)</cell><cell>687 (19.7)</cell><cell>785 (17.9)</cell><cell>0.045</cell></row><row><cell>50-59 y</cell><cell>1353 (17.2)</cell><cell>611 (17.5)</cell><cell>742 (17.0)</cell><cell>0.015</cell></row><row><cell>60-69 y</cell><cell>945 (12.0)</cell><cell>439 (12.6)</cell><cell>506 (11.6)</cell><cell>0.031</cell></row><row><cell>≥70 y</cell><cell>439 (5.6)</cell><cell>166 (4.8)</cell><cell>273 (6.2)</cell><cell>0.065</cell></row><row><cell>Male, n (%)</cell><cell>3157 (40.1)</cell><cell>1295 (37.1)</cell><cell>1862 (42.5)</cell><cell>0.111</cell></row><row><cell>Race/ethnicity, n (%)</cell><cell></cell><cell></cell><cell></cell><cell>0.362</cell></row><row><cell>Hispanic</cell><cell>697 (8.9)</cell><cell>298 (8.5)</cell><cell>399 (9.1)</cell><cell></cell></row><row><cell>Non-Hispanic Black</cell><cell>3076 (39.1)</cell><cell>1671 (47.9)</cell><cell>1405 (32.1)</cell><cell></cell></row><row><cell>Non-Hispanic White</cell><cell>2989 (38.0)</cell><cell>1026 (29.4)</cell><cell>1963 (44.8)</cell><cell></cell></row><row><cell>Other/unknown</cell><cell>1103 (14.0)</cell><cell>493 (14.1)</cell><cell>610 (13.9)</cell><cell></cell></row><row><cell>Insurance coverage, n (%)</cell><cell></cell><cell></cell><cell></cell><cell>0.082</cell></row><row><cell>Blue Cross Blue Shield, commercial, or managed care</cell><cell>5201 (66.1)</cell><cell>2279 (65.3)</cell><cell>2922(66.8)</cell><cell></cell></row><row><cell>Medicaid or managed Medicaid</cell><cell>818 (10.4)</cell><cell>398 (11.4)</cell><cell>420 (9.6)</cell><cell></cell></row><row><cell>Medicare or managed Medicare</cell><cell>1365 (17.4)</cell><cell>623 (17.9)</cell><cell>742 (17.0)</cell><cell></cell></row><row><cell>Other</cell><cell>481 (6.1)</cell><cell>188 (5.4)</cell><cell>293 (6.7)</cell><cell></cell></row><row><cell>Source of primary care, n (%)</cell><cell></cell><cell></cell><cell></cell><cell>0.118</cell></row><row><cell>Non-Penn Medicine primary care</cell><cell>2450 (31.2)</cell><cell>990 (28.4)</cell><cell>1460 (33.4)</cell><cell></cell></row><row><cell>Penn Medicine primary care</cell><cell>3354 (42.6)</cell><cell>1510 (43.3)</cell><cell>1844 (42.1)</cell><cell></cell></row><row><cell>No primary care provider</cell><cell>2061 (26.2)</cell><cell>988 (28.3)</cell><cell>1073 (24.5)</cell><cell></cell></row><row><cell>Mean body mass index (SD), kg/m 2</cell><cell>31.4 (67.38)</cell><cell>33.6 (10.87)</cell><cell>29.7 (7.21)</cell><cell>0.054</cell></row><row><cell>Preexisting conditions, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Hypertension</cell><cell>1619 (20.6)</cell><cell>800 (22.9)</cell><cell>819 (18.7)</cell><cell>0.104</cell></row><row><cell>Diabetes</cell><cell>679 (8.6)</cell><cell>383 (11.0)</cell><cell>296 (6.8)</cell><cell>0.149</cell></row><row><cell>Hyperlipidemia</cell><cell>1308 (16.6)</cell><cell>599 (17.2)</cell><cell>709 (16.2)</cell><cell>0.026</cell></row><row><cell>Chronic heart failure</cell><cell>79 (1.0)</cell><cell>44 (1.3)</cell><cell>35 (0.8)</cell><cell>0.046</cell></row><row><cell>Atrial fibrillation</cell><cell>154 (2.0)</cell><cell>54 (1.5)</cell><cell>100 (2.3)</cell><cell>0.054</cell></row><row><cell>Chronic obstructive pulmonary disease</cell><cell>83 (1.1)</cell><cell>41 (1.2)</cell><cell>42 (1.0)</cell><cell>0.021</cell></row><row><cell>Asthma</cell><cell>680 (8.6)</cell><cell>363 (10.4)</cell><cell>317 (7.2)</cell><cell>0.112</cell></row><row><cell>Chronic kidney disease</cell><cell>171 (2.2)</cell><cell>86 (2.5)</cell><cell>85 (1.9)</cell><cell>0.036</cell></row><row><cell>Cancer</cell><cell>447 (5.7)</cell><cell>201 (5.8)</cell><cell>246 (5.6)</cell><cell>0.006</cell></row><row><cell>Venous thromboembolism</cell><cell>108 (1.4)</cell><cell>59 (1.7)</cell><cell>49 (1.1)</cell><cell>0.049</cell></row><row><cell>Received a transplant</cell><cell>36 (0.5)</cell><cell>21 (0.6)</cell><cell>15 (0.3)</cell><cell>0.038</cell></row><row><cell>Dementia</cell><cell>14 (0.2)</cell><cell>5 (0.1)</cell><cell>9 (0.2)</cell><cell>0.015</cell></row><row><cell>Substance use diagnosis</cell><cell>45 (0.6)</cell><cell>11 (0.3)</cell><cell>34 (0.8)</cell><cell>0.063</cell></row><row><cell>State of residence, n (%)</cell><cell></cell><cell></cell><cell></cell><cell>0.138</cell></row><row><cell>New Jersey</cell><cell>803 (10.2)</cell><cell>276 (7.9)</cell><cell>527 (12.0)</cell><cell></cell></row><row><cell>Pennsylvania</cell><cell>6952 (88.4)</cell><cell>3160 (90.6)</cell><cell>3792 (86.6)</cell><cell></cell></row><row><cell>Other</cell><cell>110 (1.4)</cell><cell>52 (1.5)</cell><cell>58 (1.3)</cell><cell></cell></row><row><cell>Median household income of home ZIP code (SD), $</cell><cell>56 583 (29 767)</cell><cell>51 491 (27 389)</cell><cell>60 638 (30 943)</cell><cell>0.313</cell></row><row><cell>Mean hospital and office visits per patient 1 y before</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>COVID-19 testing (SD), n</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ED visit</cell><cell>0.14 (0.52)</cell><cell>0.17 (0.57)</cell><cell>0.12 (0.48)</cell><cell>0.098</cell></row><row><cell>Admission-observation</cell><cell>0.01 (0.13)</cell><cell>0.02 (0.16)</cell><cell>0.01 (0.11)</cell><cell>0.054</cell></row><row><cell>Admission-inpatient</cell><cell>0.05 (0.27)</cell><cell>0.05 (0.30)</cell><cell>0.04 (0.24)</cell><cell>0.034</cell></row><row><cell>Office visit</cell><cell>2.15 (3.51)</cell><cell>2.37 (3.74)</cell><cell>1.98 (3.30)</cell><cell>0.109</cell></row><row><cell>Prior discharge to home health and no longer receiving</cell><cell>127 (1.6)</cell><cell>65 (1.9)</cell><cell>62 (1.4)</cell><cell>0.035</cell></row><row><cell>home health, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.421</cell></row><row><cell>March</cell><cell>625 (7.9)</cell><cell>294 (8.4)</cell><cell>331 (7.6)</cell><cell></cell></row><row><cell>April</cell><cell>2282 (29.0)</cell><cell>1259 (36.1)</cell><cell>1023 (23.4)</cell><cell></cell></row></table><note xml:id="_xCRR38J"><p><s xml:id="_wkdwkfB">Mean time between COVID-19 test and result (SD), d 1.4 (2.0) 1.4 (1.6) 1.4 (2.2) 0.019 Month of index positive test, n (%)</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 -</head><label>1</label><figDesc><div><p xml:id="_y8zFgKE"><s xml:id="_VUwpt6E">Continued</s></p></div></figDesc><table><row><cell>ORIGINAL RESEARCH</cell><cell></cell><cell cols="3">Outcomes of Automated Home Monitoring for COVID-19</cell></row><row><cell>Characteristic</cell><cell>Overall</cell><cell>COVID Watch Group</cell><cell>Usual Care Group</cell><cell>Standardized</cell></row><row><cell></cell><cell>(n = 7865)</cell><cell>(n = 3488)</cell><cell>(n = 4377)</cell><cell>Mean Difference*</cell></row><row><cell>May</cell><cell>1205 (15.3)</cell><cell>655 (18.8)</cell><cell>550 (12.6)</cell><cell></cell></row><row><cell>June</cell><cell>380 (4.8)</cell><cell>128 (3.7)</cell><cell>252 (5.8)</cell><cell></cell></row><row><cell>July</cell><cell>557 (7.1)</cell><cell>182 (5.2)</cell><cell>375 (8.6)</cell><cell></cell></row><row><cell>August</cell><cell>333 (4.2)</cell><cell>93 (2.7)</cell><cell>240 (5.5)</cell><cell></cell></row><row><cell>September</cell><cell>209 (2.7)</cell><cell>67 (1.9)</cell><cell>142 (3.2)</cell><cell></cell></row><row><cell>October</cell><cell>488 (6.2)</cell><cell>186 (5.3)</cell><cell>302 (6.9)</cell><cell></cell></row><row><cell>November</cell><cell>1786 (22.7)</cell><cell>624 (17.9)</cell><cell>1162 (26.5)</cell><cell></cell></row><row><cell>ED = emergency department.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">* A standardized mean difference &gt;0.10 is generally considered statistically significant.</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_CxR9FZV"><s xml:id="_BW65U4k">Propensity Score-Weighted Baseline Characteristics</s></p></div></figDesc><table><row><cell>Characteristic</cell></row></table><note xml:id="_VE3uST4"><p><s xml:id="_MjB3CGY">]; P &lt; 0.001).</s><s xml:id="_3M3T5U8">Patients in COVID Watch had a similar number of office visits but a greater mean number of telemedicine encounters per patient (adjusted difference, 0.31 [CI, 0.27 to 0.34]; P &lt; 0.001) than usual care patients within 30 days after their date of COVID-19 test collection.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 -</head><label>2</label><figDesc><div><p xml:id="_8dXC7qe"><s xml:id="_w8B2Qea">Continued</s></p></div></figDesc><table><row><cell>Characteristic</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_NA52QTv"><s xml:id="_fmkVrMG">Mortality Outcomes</s></p></div></figDesc><table><row><cell cols="3">Outcomes of Automated Home Monitoring for COVID-19</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Outcome</cell><cell cols="2">Deaths at 30 d</cell><cell></cell><cell cols="2">Deaths at 60 d</cell></row><row><cell></cell><cell>COVID Watch Group</cell><cell>Usual Care Group</cell><cell>P Value</cell><cell>COVID Watch Group</cell><cell>Usual Care Group</cell><cell>P Value</cell></row><row><cell>Overall cohort, n</cell><cell>3488</cell><cell>4377</cell><cell></cell><cell>3488</cell><cell>4377</cell></row><row><cell>All deaths, unadjusted, n (%)</cell><cell>3 (0.09)</cell><cell>12 (0.27)</cell><cell></cell><cell>5 (0.14)</cell><cell>16 (0.37)</cell></row><row><cell>Out-of-hospital deaths, n (%)</cell><cell>0 (0)</cell><cell>6 (50.0)</cell><cell></cell><cell>0 (0.0)</cell><cell>6 (37.5)</cell></row><row><cell>In-hospital deaths, n (%)</cell><cell>3 (100.0)</cell><cell>6 (50.0)</cell><cell></cell><cell>5 (100.0)</cell><cell>10 (62.5)</cell></row><row><cell>Within the health system, n (%)</cell><cell>1 (33.3)</cell><cell>1 (16.8)</cell><cell></cell><cell>2 (40.0)</cell><cell>4 (40.0)</cell></row><row><cell>Outside the health system, n (%)</cell><cell>2 (66.7)</cell><cell>5 (83.3)</cell><cell></cell><cell>3 (60.0)</cell><cell>6 (60.0)</cell></row><row><cell>All deaths, adjusted odds ratio</cell><cell cols="2">0.32 (0.12 to 0.72)</cell><cell>0.005</cell><cell cols="2">0.34 (0.16 to 0.67)</cell><cell>0.002</cell></row><row><cell>for death for COVID Watch</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>vs. usual care (95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>All deaths, adjusted difference</cell><cell cols="2">À1.8 per 1000 (À3.1 to À0.5)</cell><cell>0.005</cell><cell cols="2">À2.5 per 1000 (À4.0 to À0.9)</cell><cell>0.002</cell></row><row><cell>in death rate for COVID</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Watch vs. usual care (95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Non-Hispanic White patients, n</cell><cell>1026</cell><cell>1963</cell><cell></cell><cell>1026</cell><cell>1963</cell></row><row><cell>All deaths, unadjusted, n (%)</cell><cell>1 (0.10)</cell><cell>7 (0.36)</cell><cell></cell><cell>1 (0.10)</cell><cell>8 (0.41)</cell></row><row><cell>Adjusted difference in mortality</cell><cell cols="2">À2.4 per 1000 (À4.3 to À0.5)</cell><cell>0.014</cell><cell cols="2">À2.5 per 1000 (À4.3 to 0.7)</cell><cell>0.007</cell></row><row><cell>rate for COVID Watch vs.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>usual care (95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Non-Hispanic Black patients, n</cell><cell>1671</cell><cell>1405</cell><cell></cell><cell>1671</cell><cell>1405</cell></row><row><cell>All deaths, unadjusted, n (%)</cell><cell>1 (0.06)</cell><cell>2 (0.14)</cell><cell></cell><cell>3 (0.18)</cell><cell>3 (0.21)</cell></row><row><cell>Adjusted difference in mortality</cell><cell cols="2">À1.3 per 1000 (À2.5 to 0)</cell><cell>0.045</cell><cell cols="2">À2.4 per 1000 (À4.2 to À0.5)</cell><cell>0.011</cell></row><row><cell>rate for COVID Watch vs.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>usual care (95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Hispanic patients, n</cell><cell>298</cell><cell>399</cell><cell></cell><cell>298</cell><cell>399</cell></row><row><cell>All deaths, unadjusted, n (%)</cell><cell>1 (0.34)</cell><cell>1 (0.25)</cell><cell></cell><cell>1 (0.34)</cell><cell>3 (0.75)</cell></row><row><cell>Adjusted difference in mortality</cell><cell cols="2">À2.3 per 1000 (À5.2 to 0.6)</cell><cell>0.118</cell><cell cols="2">À4.1 per 1000 (À8.0 to À0.1)</cell><cell>0.043</cell></row><row><cell>rate for COVID Watch vs.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>usual care (95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Patients of other race/ethnicity, n</cell><cell>493</cell><cell>610</cell><cell></cell><cell>493</cell><cell>610</cell></row><row><cell>All deaths, unadjusted, n (%)</cell><cell>0 (0.00)</cell><cell>2 (0.33)</cell><cell></cell><cell>0 (0.00)</cell><cell>2 (0.33)</cell></row><row><cell>Adjusted difference in mortality</cell><cell cols="2">À1.4 per 1000 (À3.2 to 0.4)</cell><cell>0.129</cell><cell cols="2">À1.3 per 1000 (À3.0 to 0.3)</cell><cell>0.119</cell></row><row><cell>rate for COVID Watch vs.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>usual care (95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 4 .</head><label>4</label><figDesc><div><p xml:id="_sATNuAv"><s xml:id="_nGX4dhz">Health Care Use Outcomes</s></p></div></figDesc><table><row><cell>Outcome</cell><cell></cell><cell>30 d</cell><cell></cell><cell></cell><cell>60 d</cell></row><row><cell></cell><cell>COVID Watch Group</cell><cell>Usual Care Group</cell><cell>P Value</cell><cell>COVID Watch Group</cell><cell>Usual Care Group</cell><cell>P Value</cell></row><row><cell>Overall cohort, n</cell><cell>3488</cell><cell>4377</cell><cell></cell><cell>3488</cell><cell>4377</cell></row><row><cell>ED visits, n*</cell><cell>489</cell><cell>252</cell><cell></cell><cell>602</cell><cell>350</cell></row><row><cell>Unadjusted mean per patient (SD)</cell><cell>0.10 (0.34)</cell><cell>0.04 (0.22)</cell><cell></cell><cell>0.13 (0.40)</cell><cell>0.06 (0.27)</cell></row><row><cell>Unadjusted mean within the</cell><cell>0.07 (0.28)</cell><cell>0.02 (0.15)</cell><cell></cell><cell>0.08 (0.31)</cell><cell>0.03 (0.18)</cell></row><row><cell>health system (SD)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Unadjusted mean outside the</cell><cell>0.03 (0.19)</cell><cell>0.02 (0.16)</cell><cell></cell><cell>0.04 (0.25)</cell><cell>0.03 (0.20)</cell></row><row><cell>health system (SD)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Weighted difference in mean total</cell><cell cols="2">0.06 (0.04 to 0.07)</cell><cell>&lt;0.001</cell><cell cols="2">0.06 (0.04 to 0.07)</cell><cell>&lt;0.001</cell></row><row><cell>ED visits per patient between</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>COVID Watch and usual care †</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Hospitalizations, n*</cell><cell>211</cell><cell>141</cell><cell></cell><cell>243</cell><cell>185</cell></row><row><cell>Total unadjusted mean per</cell><cell>0.06 (0.25)</cell><cell>0.03 (0.20)</cell><cell></cell><cell>0.07 (0.29)</cell><cell>0.04 (0.25)</cell></row><row><cell>patient (SD)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Unadjusted mean within the</cell><cell>0.04 (0.22)</cell><cell>0.02 (0.18)</cell><cell></cell><cell>0.05 (0.25)</cell><cell>0.03 (0.22)</cell></row><row><cell>health system (SD)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Unadjusted mean outside the</cell><cell>0.02 (0.13)</cell><cell>0.01 (0.10)</cell><cell></cell><cell>0.02 (0.15)</cell><cell>0.01 (0.11)</cell></row><row><cell>health system (SD)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Adjusted difference in mean total</cell><cell cols="2">0.03 (0.01 to 0.04)</cell><cell>&lt;0.001</cell><cell cols="2">0.02 (0.01 to 0.03)</cell><cell>&lt;0.001</cell></row><row><cell>hospitalizations per patient</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>between COVID Watch and</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>usual care † (95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>DAOH ‡</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Unadjusted mean per patient (SD)</cell><cell>29.5 (2.3)</cell><cell>29.7 (3.0)</cell><cell></cell><cell>59.4 (3.4)</cell><cell>59.5 (3.7)</cell></row><row><cell>Adjusted difference in mean</cell><cell cols="2">À0.2 (À0.3 to À0.1)</cell><cell>&lt;0.001</cell><cell cols="2">À0.1 (À0.3 to 0.03)</cell><cell>0.103</cell></row><row><cell>DAOH per patient between</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>COVID Watch and usual care †</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Outpatient office visits within the</cell><cell>473</cell><cell>601</cell><cell></cell><cell>927</cell><cell>1270</cell></row><row><cell>health system, n</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Unadjusted mean per patient (SD)</cell><cell>0.14 (0.40)</cell><cell>0.14 (0.41)</cell><cell></cell><cell>0.27 (0.62)</cell><cell>0.29 (0.67)</cell></row><row><cell>Adjusted difference in mean office</cell><cell cols="2">0.01 (À0.01 to 0.02)</cell><cell>0.58</cell><cell cols="2">À0.01 (À0.04 to 0.02)</cell><cell>0.67</cell></row><row><cell>visits per patient between</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>COVID Watch and usual care †</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Telemedicine visits within the</cell><cell>2170</cell><cell>1265</cell><cell></cell><cell>2724</cell><cell>1677</cell></row><row><cell>health system, n §</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Unadjusted mean per patient (SD)</cell><cell>0.62 (1.03)</cell><cell>0.29 (0.61)</cell><cell></cell><cell>0.78 (1.26)</cell><cell>0.38 (0.78)</cell></row><row><cell>Adjusted difference in mean</cell><cell cols="2">0.31 (0.27 to 0.34)</cell><cell>&lt;0.001</cell><cell cols="2">0.34 (0.30 to 0.39)</cell><cell>&lt;0.001</cell></row><row><cell>telemedicine visits per patient</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>between COVID Watch and</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>usual care † (95% CI)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_jBXTYUJ"><p>DAOH = days alive and out of the hospital; ED = emergency department. * ED visits include discharges and hospitalizations. Hospitalizations included inpatient admissions and observation stays admitted from the ED. † Propensity score-weighted model incorporating all variables listed in Table2</p><p><s xml:id="_a3kR3ex">.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 5 .</head><label>5</label><figDesc><div><p><s xml:id="_7dYbmsF">Timing and Severity of Initial Presentations to Health System EDs Within 30 Days*This table does not include patients who presented to any of 53 hospitals outside the health system captured in the regional health information exchange.There were a total of 196 ED encounters to hospitals outside the health system (COVID Watch [n = 105], usual care [n = 91]).†Propensity</s><s xml:id="_63EYqzm">score-weighted model incorporating all variables listed in Table2.</s></p></div></figDesc><table><row><cell>Outcome</cell><cell>COVID Watch Group</cell><cell>Usual Care Group</cell><cell>Adjusted Difference Between</cell><cell>P Value</cell></row><row><cell></cell><cell>(n = 330)</cell><cell>(n = 139)</cell><cell>COVID Watch and Usual</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Care † (95% CI)</cell><cell></cell></row><row><cell>Mean time to presentation to the ED after index</cell><cell>6.1 (5.5)</cell><cell>9.0 (8.4)</cell><cell>À2.9 (À4.1 to À1.7)</cell><cell>&lt; 0.001</cell></row><row><cell>COVID-19 test collection (SD), d</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Mean time to receipt of dexamethasone after index</cell><cell>5.1 (2.7)</cell><cell>7.7 (6.6)</cell><cell>À3.0 (À5.6 to À0.4)</cell><cell>0.026</cell></row><row><cell>COVID-19 test collection (SD), d</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Mean lowest recorded oxygen saturation percent-</cell><cell>93.4 (7.2)</cell><cell>92.5 (10.1)</cell><cell>0.8 (À0.8 to 2.3)</cell><cell>0.35</cell></row><row><cell>age in the ED (SD), %</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Supplemental oxygen provided in the ED, n (%)</cell><cell>88 (26.7)</cell><cell>38 (27.5)</cell><cell>0.2 (À5.6 to 5.9)</cell><cell>0.95</cell></row><row><cell>Mean maximum temperature in the ED (SD), C</cell><cell>37.7 (2.7)</cell><cell>37.4 (1.6)</cell><cell>0.4 (À0.1 to 0.9)</cell><cell>0.110</cell></row><row><cell>Mean lowest recorded SBP in the ED (SD), mm Hg</cell><cell>119.2 (16.1)</cell><cell>117.0 (14.9)</cell><cell>1.3 (À1.5 to 4.1)</cell><cell>0.36</cell></row><row><cell>Intubated and required ventilator support, n (%)</cell><cell>6 (1.8)</cell><cell>6 (4.3)</cell><cell>À1.5 (À3.5 to 0.6)</cell><cell>0.154</cell></row><row><cell cols="2">ED = emergency department; SBP = systolic blood pressure.</cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_s7Wu6N3"><p><s xml:id="_52vmUX8">*</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_dbqmAbR"><s xml:id="_4U5sFf7">Annals.org Annals of Internal Medicine • Vol. 175</s><s xml:id="_qHq3NMQ">No. 2 • February 2022 181 Downloaded from https://annals.org</s><s xml:id="_bCBbraM">by University of Iowa Libraries on 07/28/2025.</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="182" xml:id="foot_1"><p xml:id="_Cggmqjm"><s xml:id="_dennKjs">Annals of Internal Medicine • Vol. 175</s><s xml:id="_TrnGKhK">No. 2 • February 2022 Annals.org</s><s xml:id="_VnEaZpS">Downloaded from https://annals.org</s><s xml:id="_dBPtMqc">by University of Iowa Libraries on 07/28/2025.</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_DAjDGtw"><s xml:id="_QHfrPwF">Annals.org Annals of Internal Medicine • Vol. 175</s><s xml:id="_MeJfFFR">No. 2 • February 2022 183 Downloaded from https://annals.org</s><s xml:id="_RgGZ8Vb">by University of Iowa Libraries on 07/28/2025.</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="184" xml:id="foot_3"><p xml:id="_qFmA9qJ"><s xml:id="_uJUeTPc">Annals of Internal Medicine • Vol. 175</s><s xml:id="_wqDjyrG">No. 2 • February 2022 Annals.org</s><s xml:id="_wu8vbMB">Downloaded from https://annals.org</s><s xml:id="_aK2WwSr">by University of Iowa Libraries on 07/28/2025.</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_4"><p xml:id="_JBdS7RC"><s xml:id="_6ynd4HQ">Annals.org Annals of Internal Medicine • Vol. 175</s><s xml:id="_wKhUga6">No. 2 • February 2022 185 Downloaded from https://annals.org</s><s xml:id="_NgwACjg">by of Iowa Libraries on 07/28/2025.</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="186" xml:id="foot_5"><p xml:id="_nVkZ6wv"><s xml:id="_egkBgMJ">Annals of Internal Medicine • Vol. 175</s><s xml:id="_vcyn4Yu">No. 2 • February 2022 Annals.org</s><s xml:id="_vBJaJuh">Downloaded from https://annals.org</s><s xml:id="_PdFnKzD">by of Iowa Libraries on 07/28/2025.</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="188" xml:id="foot_6"><p xml:id="_qUjsJXY"><s xml:id="_WVjYVeg">Annals of Internal Medicine • Vol. 175</s><s xml:id="_8cPNw2j">No. 2 • February 2022 Annals.org</s><s xml:id="_fkCbwY6">Downloaded from https://annals.org</s><s xml:id="_mQf98RF">by of Iowa Libraries on 07/28/2025.</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_7"><p xml:id="_M268sCE"><s xml:id="_Pwb3x3S">Annals of Internal Medicine • Vol. 175</s><s xml:id="_2k48apw">No. 2 • February 2022 Annals.org</s><s xml:id="_Ayf5YGf">Downloaded from https://annals.org</s><s xml:id="_bDdUfkc">by of Iowa Libraries on 07/28/2025.</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div xml:id="_4gcgXsm"><p xml:id="_JDJ563y"><s xml:id="_WUbNfMZ"><rs type="institution">From Center for Emergency Care Policy and Research, Department of Emergency Medicine, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine</rs>, and <rs type="affiliation">Leonard Davis Institute of Health Economics, University of Pennsylvania</rs>, and <rs type="affiliation">Center for Health Care Innovation, University of Pennsylvania Health System, Philadelphia, Pennsylvania</rs> (<rs type="person">M.K.D.</rs>); <rs type="affiliation">Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine and Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania (A.U.M.</rs>); <rs type="affiliation">Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Wharton School</rs>, and <rs type="affiliation">Leonard Davis Institute of Health Economics, University of Pennsylvania, and Center for Health Care Innovation, University of Pennsylvania Health System, Philadelphia, Pennsylvania (D.A.A</rs>.); <rs type="affiliation">Center for Emergency Care Policy and Research, Department of Emergency Medicine, and Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine</rs>, and <rs type="affiliation">Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania (R.</rs>X.); <rs type="affiliation">Center for Emergency Care Policy and Research, Department of Emergency Medicine, Perelman School of Medicine</rs>, and <rs type="affiliation">Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania (A.</rs><rs type="person">S.K.</rs>, <rs type="person">A.B.F.</rs>, <rs type="person">Z.F.M.</rs>); <rs type="institution">Center for Emergency Care Policy and Research, Department of Emergency Medicine</rs>, <rs type="affiliation">Perelman School of Medicine, University of Pennsylvania</rs>, and <rs type="affiliation">Center for Health Care Innovation, University of Pennsylvania Health System, Philadelphia, Pennsylvania</rs> (K.C.L.); <rs type="affiliation">Department of Neurology, Perelman School of Medicine, University of Pennsylvania</rs>, Acknowledgment: The authors thank <rs type="person">P.J. Brennan</rs>; <rs type="person">C. William Hanson III</rs>; <rs type="person">Susan Day</rs>; <rs type="person">Michael Y. Kopinsky</rs>; <rs type="person">Roy Rosin</rs>; the <rs type="affiliation">COVID Watch nursing</rs> and clinical team; <rs type="person">Jessie Hemmons</rs>; <rs type="person">Dina Abdel-Rahman</rs>; <rs type="person">Jeffrey Ebert</rs>; <rs type="person">Medha Ghosh</rs>; <rs type="person">Julianne Reilly</rs>; <rs type="person">Bill Marella</rs> and colleagues at <rs type="affiliation">HealthShare Exchange (Philadelphia, Pennsylvania</rs>); and their patient and stakeholder advisory board: <rs type="person">Jill Baren</rs>, <rs type="person">Brooke Feldman</rs>, <rs type="person">Janet Williams</rs>, <rs type="person">Dennis Burroughs</rs>, <rs type="person">Utibe R. Essien</rs>, and <rs type="person">Carlos Pascual Sanchez</rs>.</s><s xml:id="_7WBxsyE">Grant Support: By a grant from the <rs type="funder">Patient-Centered Outcomes Research Institute</rs> (<rs type="grantNumber">COVID-2020C2-10830</rs>).</s><s xml:id="_zkU5pNJ">The authors were also supported by the <rs type="funder">National Institutes of Health</rs> (<rs type="grantNumber">K23HD090272001</rs> to <rs type="person">Dr. Delgado</rs> and <rs type="grantNumber">K08AG065444</rs> to <rs type="person">Dr. Chaiyachati</rs>) and with a philanthropic grant from the <rs type="funder">Abramson Family Foundation</rs> (<rs type="person">Dr.Delgado</rs>).</s><s xml:id="_JcXhvZt">Disclosures: Disclosures can be viewed at <ref type="url" target="www.acponline.org/">www.acponline.org/</ref></s><s xml:id="_rFtbc7t">authors/icmje/ConflictOfInterestForms.do?msNum=M21-2019.</s><s xml:id="_UASGZjD">Reproducible Research Statement: Study protocol: See the Supplement (available at Annals.org).</s><s xml:id="_MefgJHu">Statistical code: Available at <ref type="url" target="www.besafir.org/covidwatchcode">www.besafir.org/covidwatchcode</ref>.</s><s xml:id="_Fh8pQ83">Data set: Not available.</s><s xml:id="_Tnj3bRx">Corresponding Author: <rs type="person">M. Kit Delgado</rs>, MD, MS, <rs type="affiliation">Perelman School of Medicine, University of Pennsylvania</rs>, <rs type="affiliation">933 Blockley Hall</rs>, <rs type="affiliation">423 Guardian Drive</rs>, Philadelphia, PA 19104; e-mail, mucio.delgado@pennmedicine.upenn.edu.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_Mc2CgeK">
					<idno type="grant-number">COVID-2020C2-10830</idno>
				</org>
				<org type="funding" xml:id="_4NDg98U">
					<idno type="grant-number">K23HD090272001</idno>
				</org>
				<org type="funding" xml:id="_yQbFf8u">
					<idno type="grant-number">K08AG065444</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_4NmsvD6"><p xml:id="_qkXTPzS"><s xml:id="_gyVHd7D">Author contributions are available at Annals.org.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<idno type="DOI">10.46234/ccdcw2020.094</idno>
		<ptr target="https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscaseson23" />
		<title level="m" xml:id="_wTR2u72">Trends in number of COVID-19 cases and deaths in the US reported to CDC, by state/ territory</title>
		<imprint>
			<date type="published" when="2021-04">April 2021</date>
		</imprint>
		<respStmt>
			<orgName>Centers for Disease Control and Prevention</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Centers for Disease Control and Prevention. Trends in number of COVID-19 cases and deaths in the US reported to CDC, by state/ territory. Accessed at https://covid.cdc.gov/covid-data-tracker/# trends_dailytrendscases on 23 April 2021.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_4HRCjTs">Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 -COVID-NET, 14 states</title>
		<author>
			<persName><forename type="first">S</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Whitaker</surname></persName>
		</author>
		<idno type="DOI">10.15585/mmwr.mm6915e3</idno>
		<idno type="PMID">32298251</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Hchpd7G">MMWR Morb Mortal Wkly Rep</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="458" to="464" />
			<date type="published" when="2020">March 1-30, 2020. 2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Garg S, Kim L, Whitaker M, et al. Hospitalization rates and char- acteristics of patients hospitalized with laboratory-confirmed coro- navirus disease 2019 -COVID-NET, 14 states, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458-464. [PMID: 32298251] doi:10.15585/mmwr.mm6915e3</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<idno type="DOI">10.1111/j.1744-6155.2010.00262.x</idno>
		<ptr target="www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/steps-when-sick.htmlon16" />
		<title level="m" xml:id="_VAMAXMu">COVID-19: what to do if you are sick</title>
		<imprint>
			<date type="published" when="2020-05">May 2020</date>
		</imprint>
		<respStmt>
			<orgName>Centers for Disease Control and Prevention</orgName>
		</respStmt>
	</monogr>
	<note>Accessed at</note>
	<note type="raw_reference">Centers for Disease Control and Prevention. COVID-19: what to do if you are sick. Accessed at www.cdc.gov/coronavirus/2019- ncov/if-you-are-sick/steps-when-sick.html on 16 May 2020.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_Dn4m83H">Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Mcgoogan</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2020.2648</idno>
		<idno type="PMID">32091533</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XVbTJhZ">JAMA</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="1239" to="1242" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-1242. [PMID: 32091533] doi:10.1001/jama.2020.2648</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_ePtJkkC">Mild or moderate Covid-19</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Gandhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Del</forename><surname>Rio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<idno type="DOI">10.1056/nejmcp2009249</idno>
		<idno type="PMID">32329974</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_z9gnMRr">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">383</biblScope>
			<biblScope unit="page" from="1757" to="1766" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gandhi RT, Lynch JB, Del Rio C. Mild or moderate Covid-19. N Engl J Med. 2020;383:1757-1766. [PMID: 32329974] doi:10.1056/ NEJMcp2009249</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_hUuhHsW">Variation in US hospital mortality rates for patients admitted with COVID-19 during the first 6 months of the pandemic</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Sheils</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Islam</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2020.8193</idno>
		<idno type="PMID">33351068</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4mw6nVN">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="page" from="471" to="478" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Asch DA, Sheils NE, Islam MN, et al. Variation in US hospital mor- tality rates for patients admitted with COVID-19 during the first 6 months of the pandemic. JAMA Intern Med. 2021;181:471-478. [PMID: 33351068] doi:10.1001/jamainternmed.2020.8193</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_bQrrq5v">Clinical trends among US adults hospitalized with COVID-19, March to December 2020. A cross-sectional study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pham</surname></persName>
		</author>
		<idno type="DOI">10.7326/m21-1991</idno>
		<idno type="PMID">34370517</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EXc2ks5">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="page" from="1409" to="1419" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Garg S, Patel K, Pham H, et al. Clinical trends among US adults hos- pitalized with COVID-19, March to December 2020. A cross-sectional study. Ann Intern Med. 2021;174:1409-1419. [PMID: 34370517] doi:10.7326/M21-1991</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_ZV6yqPQ">Where are all the patients? Addressing Covid-19 fear to encourage sick patients to seek emergency care</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hawkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Langness</surname></persName>
		</author>
		<idno type="DOI">10.1056/CAT.20.0193</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kcAbY9f">NEJM Catal Innov Care Deliv</title>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wong LE, Hawkins JE, Langness S, et al. Where are all the patients? Addressing Covid-19 fear to encourage sick patients to seek emergency care. NEJM Catal Innov Care Deliv. 2020. doi:10.1056/ CAT.20.0193</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_tmAs5QY">National Syndromic Surveillance Program Community of Practice. Impact of the COVID-19 pandemic on emergency department visits -United States</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Hartnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kite-Powell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Devies</surname></persName>
		</author>
		<idno type="DOI">10.15585/mmwr.mm6923e1</idno>
		<idno type="PMID">32525856</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AkZg936">MMWR Morb Mortal Wkly Rep</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="699" to="704" />
			<date type="published" when="2019-01-01">January 1, 2019-May 30, 2020. 2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hartnett KP, Kite-Powell A, DeVies J, et al; National Syndromic Surveillance Program Community of Practice. Impact of the COVID-19 pandemic on emergency department visits -United States, January 1, 2019-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:699-704. [PMID: 32525856] doi:10.15585/mmwr.mm6923e1</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_Qp2S4mY">Admissions to Veterans Affairs hospitals for emergency conditions during the COVID-19 pandemic</title>
		<author>
			<persName><forename type="first">A</forename><surname>Baum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Schwartz</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2020.9972</idno>
		<idno type="PMID">32501493</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gxjsR8R">JAMA</title>
		<imprint>
			<biblScope unit="volume">324</biblScope>
			<biblScope unit="page" from="96" to="99" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Baum A, Schwartz MD. Admissions to Veterans Affairs hospitals for emergency conditions during the COVID-19 pandemic. JAMA. 2020;324:96-99. [PMID: 32501493] doi:10.1001/jama.2020.9972</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_Qts7dam">The value of remote monitoring for the COVID-19 pandemic</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Thamman</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2020.0134</idno>
		<idno type="PMID">32384251</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_T5jZ2VC">Telemed J E Health</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1110" to="1112" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Watson AR, Wah R, Thamman R. The value of remote monitoring for the COVID-19 pandemic. Telemed J E Health. 2020;26:1110- 1112. [PMID: 32384251] doi:10.1089/tmj.2020.0134</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_UJCdExH">Remote monitoring of patients with Covid-19: design, implementation, and outcomes of the first 3,000 patients in COVID Watch</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">U</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Balachandran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Do</surname></persName>
		</author>
		<idno type="DOI">10.1056/CAT.20.0342</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Cj9vYgp">NEJM Catal Innov Care Deliv</title>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Morgan AU, Balachandran M, Do D, et al. Remote monitoring of patients with Covid-19: design, implementation, and outcomes of the first 3,000 patients in COVID Watch. NEJM Catal Innov Care Deliv. 2020. doi:10.1056/CAT.20.0342</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_xfxj3wk">Virtually perfect? Telemedicine for Covid-19</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hollander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Carr</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmp2003539</idno>
		<idno type="PMID">32160451</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9CA5u8f">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope unit="page" from="1679" to="1681" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382:1679-1681. [PMID: 32160451] doi:10.1056/NEJMp2003539</note>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<author>
			<orgName type="collaboration">HealthShare Exchange</orgName>
		</author>
		<idno type="DOI">10.2172/1827863</idno>
		<ptr target="www.healthshareexchange.org/current-participantson30" />
		<title level="m" xml:id="_3xZqYtG">Current participants</title>
		<imprint>
			<date type="published" when="2021-03">March 2021</date>
		</imprint>
	</monogr>
	<note>Accessed at</note>
	<note type="raw_reference">HealthShare Exchange. Current participants. Accessed at www. healthshareexchange.org/current-participants on 30 March 2021.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_UNkuf6S">Standardised Endpoints in Perioperative Medicine-Core Outcome Measures in Perioperative and Anaesthetic Care (StEP-COMPAC) Group. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine initiative: patient-centred outcomes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Moonesinghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Air</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Boney</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bja.2019.07.020</idno>
		<idno type="PMID">31493848</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GVPyauG">Br J Anaesth</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="664" to="670" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moonesinghe SR, Jackson AIR, Boney O, et al; Standardised Endpoints in Perioperative Medicine-Core Outcome Measures in Perioperative and Anaesthetic Care (StEP-COMPAC) Group. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine initiative: patient-centred outcomes. Br J Anaesth. 2019;123:664-670. [PMID: 31493848] doi:10.1016/j.bja.2019.07.020</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_DZYZDA3">Days alive and out of hospital: validation of a patient-centered outcome for perioperative medicine</title>
		<author>
			<persName><forename type="first">A</forename><surname>Jerath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Wijeysundera</surname></persName>
		</author>
		<idno type="DOI">10.1097/aln.0000000000002701</idno>
		<idno type="PMID">31094760</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qtgys6M">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="84" to="93" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jerath A, Austin PC, Wijeysundera DN. Days alive and out of hospital: validation of a patient-centered outcome for perioperative medicine. Anesthesiology. 2019;131:84-93. [PMID: 31094760] doi:10.1097/ALN. 0000000000002701</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_ANuJhGh">Alirocumab reduces total hospitalizations and increases days alive and out of hospital in the ODYSSEY OUTCOMES trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Szarek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Steg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dicenso</surname></persName>
		</author>
		<idno type="DOI">10.1161/circoutcomes.119.005858</idno>
		<idno type="PMID">31707826</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hBxTtMZ">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">5858</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Szarek M, Steg PG, DiCenso D, et al. Alirocumab reduces total hospi- talizations and increases days alive and out of hospital in the ODYSSEY OUTCOMES trial. Circ Cardiovasc Qual Outcomes. 2019;12:e005858. [PMID: 31707826] doi:10.1161/CIRCOUTCOMES.119.005858</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_6vePYAt">Days alive and out of hospital: exploring a patient-centered, pragmatic outcome in a clinical trial of patients with acute coronary syndromes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Fanaroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cyr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Neely</surname></persName>
		</author>
		<idno type="DOI">10.1161/circoutcomes.118.004755</idno>
		<idno type="PMID">30562068</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5cwnzDA">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">4755</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fanaroff AC, Cyr D, Neely ML, et al. Days alive and out of hospital: exploring a patient-centered, pragmatic outcome in a clinical trial of patients with acute coronary syndromes. Circ Cardiovasc Qual Outcomes. 2018;11: e004755. [PMID: 30562068] doi:10.1161/CIRCOUTCOMES.118.004755</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_rQVy6BH">Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized ORIGINAL RESEARCH Outcomes of Automated Home Monitoring for COVID-19 patients with COVID-19</title>
		<author>
			<persName><forename type="first">W</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ou</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2020.2033</idno>
		<idno type="PMID">32396163</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VpVdFFm">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="1081" to="1089" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note>Treatment Expert Group for COVID-19</note>
	<note type="raw_reference">Liang W, Liang H, Ou L, et al; China Medical Treatment Expert Group for COVID-19. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized ORIGINAL RESEARCH Outcomes of Automated Home Monitoring for COVID-19 patients with COVID-19. JAMA Intern Med. 2020;180:1081-1089. [PMID: 32396163] doi:10.1001/jamainternmed.2020.2033</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_b9tjQUA">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</title>
		<author>
			<persName><forename type="first">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(20)30183-5</idno>
		<idno type="PMID">31986264</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qXDTWwt">Lancet</title>
		<imprint>
			<biblScope unit="volume">395</biblScope>
			<biblScope unit="page" from="497" to="506" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. [PMID: 31986264] doi:10.1016/S0140-6736(20) 30183-5</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_GxGCePD">Return hospital admissions among 1419 COVID-19 patients discharged from five U.S. emergency departments</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Kilaru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Snider</surname></persName>
		</author>
		<idno type="DOI">10.1111/acem.14117</idno>
		<idno type="PMID">32853423</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QqyrUwn">Acad Emerg Med</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1039" to="1042" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kilaru AS, Lee K, Snider CK, et al. Return hospital admissions among 1419 COVID-19 patients discharged from five U.S. emer- gency departments. Acad Emerg Med. 2020;27:1039-1042. [PMID: 32853423] doi:10.1111/acem.14117</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_vF5N6hQ">Risk factors for Covid-19 severity and fatality: a structured literature review</title>
		<author>
			<persName><forename type="first">D</forename><surname>Wolff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Hickey</surname></persName>
		</author>
		<idno type="DOI">10.1007/s15010-020-01509-1</idno>
		<idno type="PMID">32860214</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_G4afJeE">Infection</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="15" to="28" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wolff D, Nee S, Hickey NS, et al. Risk factors for Covid-19 sever- ity and fatality: a structured literature review. Infection. 2021;49:15- 28. [PMID: 32860214] doi:10.1007/s15010-020-01509-1</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_MTSnwzG">Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Haimovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Ravindra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stoytchev</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.annemergmed.2020.07.022</idno>
		<idno type="PMID">33012378</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GYQf5yE">Ann Emerg Med</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="442" to="453" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haimovich AD, Ravindra NG, Stoytchev S, et al. Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation. Ann Emerg Med. 2020;76:442-453. [PMID: 33012378] doi:10.1016/j.annemergmed.2020.07.022</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_DHAqAK8">Factors associated with death in critically ill patients with coronavirus disease 2019 in the US</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Hayek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2020.3596</idno>
		<idno type="PMID">32667668</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9428htX">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="1436" to="1447" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gupta S, Hayek SS, Wang W, et al; STOP-COVID Investigators. Factors associated with death in critically ill patients with coronavi- rus disease 2019 in the US. JAMA Intern Med. 2020;180:1436- 1447. [PMID: 32667668] doi:10.1001/jamainternmed.2020.3596</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_8mEr5ms">Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Stuart</surname></persName>
		</author>
		<idno type="DOI">10.1002/sim.6607</idno>
		<idno type="PMID">26238958</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RJ5WGDt">Stat Med</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="3661" to="3679" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propen- sity score to estimate causal treatment effects in observational stud- ies. Stat Med. 2015;34:3661-79. [PMID: 26238958] doi:10.1002/ sim.6607</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_8cDfUau">Rapid implementation of an outpatient Covid-19 monitoring program</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kricke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Roemer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Barnard</surname></persName>
		</author>
		<idno type="DOI">10.1056/CAT.20.0214</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KBFHs3G">NEJM Catal Innov Care Deliv</title>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kricke G, Roemer PE, Barnard C, et al. Rapid implementation of an outpatient Covid-19 monitoring program. NEJM Catal Innov Care Deliv. 2020. doi:10.1056/CAT.20.0214</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_QFw3Hgf">Virtual health care for community management of patients with COVID-19 in Australia: observational cohort study</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">R</forename><surname>Hutchings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dearing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jagers</surname></persName>
		</author>
		<idno type="DOI">10.2196/21064</idno>
		<idno type="PMID">33687341</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zKfvRKM">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page">21064</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hutchings OR, Dearing C, Jagers D, et al. Virtual health care for community management of patients with COVID-19 in Australia: observational cohort study. J Med Internet Res. 2021;23:e21064. [PMID: 33687341] doi:10.2196/21064</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_yZqhVaA">A novel large scale integrated telemonitoring program for COVID-19</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sankineni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Olaleye</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2020.0384</idno>
		<idno type="PMID">33544043</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PzztrKW">Telemed J E Health</title>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shaw JG, Sankineni S, Olaleye CA, et al. A novel large scale integrated telemonitoring program for COVID-19. Telemed J E Health. 2021. [PMID: 33544043] doi:10.1089/tmj.2020.0384</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_PK6NaY5">Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement -United States, March 1-May 31, 2020</title>
		<author>
			<persName><forename type="first">A</forename><surname>Moreland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Herlihy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Tynan</surname></persName>
		</author>
		<idno type="DOI">10.15585/mmwr.mm6935a2</idno>
		<idno type="PMID">32881851</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KGyjhvj">MMWR Morb Mortal Wkly Rep</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1198" to="1203" />
			<date type="published" when="2020">2020</date>
		</imprint>
		<respStmt>
			<orgName>Public Health Law Program</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Moreland A, Herlihy C, Tynan MA, et al; CDC Public Health Law Program. Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement -United States, March 1-May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1198-1203. [PMID: 32881851] doi:10.15585/mmwr.mm6935a2</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_zUUVnN5">Association of stay-at-home orders with COVID-19 hospitalizations in 4 states</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Karaca-Mandic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Georgiou</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2020.9176</idno>
		<idno type="PMID">32459287</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fADN2C7">JAMA</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="2522" to="2524" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sen S, Karaca-Mandic P, Georgiou A. Association of stay-at-home orders with COVID-19 hospitalizations in 4 states. JAMA. 2020;323:2522- 2524. [PMID: 32459287] doi:10.1001/jama.2020.9176</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_s2UKwjr">Delayed emergencies: the composition and magnitude of non-respiratory emergency department visits during the COVID-19 pandemic</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Barfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>David</surname></persName>
		</author>
		<idno type="DOI">10.1002/emp2.12349</idno>
		<idno type="PMID">33490998</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mPMt7qQ">J Am Coll Emerg Physicians Open</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">12349</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Friedman AB, Barfield D, David G, et al. Delayed emergencies: the composition and magnitude of non-respiratory emergency department visits during the COVID-19 pandemic. J Am Coll Emerg Physicians Open. 2021;2:e12349. [PMID: 33490998] doi:10.1002/ emp2.12349</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_tSwGhR9">Do not stay at home: we are ready for you</title>
		<author>
			<persName><forename type="first">J</forename><surname>Deerberg-Wittram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Knothe</surname></persName>
		</author>
		<idno type="DOI">10.1056/CAT.20.0146</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KfwSV3S">NEJM Catal Innov Care Deliv</title>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Deerberg-Wittram J, Knothe C. Do not stay at home: we are ready for you. NEJM Catal Innov Care Deliv. 2020. doi:10.1056/ CAT.20.0146</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_vjWjJjz">Trends in emergency department visits and hospital admissions in health care systems in 5 states in the first months of the COVID-19 pandemic in the US</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Jeffery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D'</forename><surname>Onofrio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Paek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2020.3288</idno>
		<idno type="PMID">32744612</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_baMgpkC">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="1328" to="1333" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jeffery MM, D&apos;Onofrio G, Paek H, et al. Trends in emergency department visits and hospital admissions in health care systems in 5 states in the first months of the COVID-19 pandemic in the US. JAMA Intern Med. 2020;180:1328-1333. [PMID: 32744612] doi:10.1001/ jamainternmed.2020.3288</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_XR6wcAp">Hospital volumes of 5 medical emergencies in the COVID-19 pandemic in 2 US medical centers</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Bhambhvani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Rodrigues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Yu</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2020.3982</idno>
		<idno type="PMID">33104161</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_98MWyna">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="page" from="272" to="274" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bhambhvani HP, Rodrigues AJ, Yu JS, et al. Hospital volumes of 5 medical emergencies in the COVID-19 pandemic in 2 US medical centers. JAMA Intern Med. 2021;181:272-274. [PMID: 33104161] doi:10.1001/ jamainternmed.2020.3982</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_Y7Mdxde">Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic [Letter]</title>
		<author>
			<persName><forename type="first">S</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Albaghdadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Meraj</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2020.04.011</idno>
		<idno type="PMID">32283124</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Mewthmn">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="2871" to="2872" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic [Letter]. J Am Coll Cardiol. 2020;75:2871- 2872. [PMID: 32283124] doi:10.1016/j.jacc.2020.04.011</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_r3AX2Fx">Excess cardiac arrest in the community during the COVID-19 pandemic [Letter]</title>
		<author>
			<persName><forename type="first">M</forename><surname>Holland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hulac</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jcin.2020.06.022</idno>
		<idno type="PMID">32819492</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hsqtMbX">JACC Cardiovasc Interv</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1968" to="1969" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Holland M, Burke J, Hulac S, et al. Excess cardiac arrest in the community during the COVID-19 pandemic [Letter]. JACC Cardiovasc Interv. 2020;13:1968-1969. [PMID: 32819492] doi:10.1016/j.jcin.2020 .06.022</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_rJ8KKG2">Excess out-of-hospital deaths during the COVID-19 outbreak: evidence of pulmonary embolism as a main determinant [Letter</title>
		<author>
			<persName><forename type="first">J</forename><surname>Benzakoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hmeydia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Delabarde</surname></persName>
		</author>
		<idno type="DOI">10.1002/ejhf.1916</idno>
		<idno type="PMID">32463538</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3vWt4Rh">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1046" to="1047" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Benzakoun J, Hmeydia G, Delabarde T, et al. Excess out-of-hos- pital deaths during the COVID-19 outbreak: evidence of pulmonary embolism as a main determinant [Letter]. Eur J Heart Fail. 2020;22:1046-1047. [PMID: 32463538] doi:10.1002/ejhf.1916</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_A93PDaX">Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a populationbased, observational study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Marijon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Karam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jost</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2468-2667(20)30117-1</idno>
		<idno type="PMID">32473113</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3cFFHZb">Lancet Public Health</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="437" to="e443" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Marijon E, Karam N, Jost D, et al. Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population- based, observational study. Lancet Public Health. 2020;5:e437- e443. [PMID: 32473113] doi:10.1016/S2468-2667(20)30117-1</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_s6mjy7E">The association of structural inequities and race with out-of-hospital sudden death during the COVID-19 pandemic</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Mountantonakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Epstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Coleman</surname></persName>
		</author>
		<idno type="DOI">10.1161/circep.120.009646</idno>
		<idno type="PMID">33835821</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kStmev6">Circ Arrhythm Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">9646</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mountantonakis SE, Epstein LM, Coleman K, et al; Northwell COVID-19 Research Consortium. The association of structural inequities and race with out-of-hospital sudden death during the COVID-19 pandemic. Circ Arrhythm Electrophysiol. 2021;14: e009646. [PMID: 33835821] doi:10.1161/CIRCEP.120.009646</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_S7eRv9s">Dexamethasone in hospitalized patients with Covid-19</title>
		<author>
			<persName><forename type="first">P</forename><surname>Horby</surname></persName>
			<affiliation>
				<orgName type="collaboration">RECOVERY Collaborative Group</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Lim</surname></persName>
			<affiliation>
				<orgName type="collaboration">RECOVERY Collaborative Group</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Emberson</surname></persName>
			<affiliation>
				<orgName type="collaboration">RECOVERY Collaborative Group</orgName>
			</affiliation>
		</author>
		<idno type="DOI">10.1056/nejmoa2021436</idno>
		<idno type="PMID">32678530</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HcmPxtU">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">384</biblScope>
			<biblScope unit="page" from="693" to="704" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Horby P, Lim WS, Emberson JR, et al; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693-704. [PMID: 32678530] doi:10.1056/ NEJMoa2021436</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_HHnEmym">Role of the early shortcourse corticosteroids treatment in ARDS caused by COVID-19: a single-center, retrospective analysis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Boglione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Olivieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rostagno</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.advms.2021.04.002</idno>
		<idno type="PMID">34022675</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wwAyVVj">Adv Med Sci</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="262" to="268" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Boglione L, Olivieri C, Rostagno R, et al. Role of the early short- course corticosteroids treatment in ARDS caused by COVID-19: a single-center, retrospective analysis. Adv Med Sci. 2021;66:262- 268. [PMID: 34022675] doi:10.1016/j.advms.2021.04.002</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_kdXU9MS">Early short-course corticosteroids in hospitalized patients with COVID-19</title>
		<author>
			<persName><forename type="first">R</forename><surname>Fadel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vahia</surname></persName>
		</author>
		<idno type="DOI">10.1093/cid/ciaa601</idno>
		<idno type="PMID">32427279</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vATrney">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="2114" to="2120" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fadel R, Morrison AR, Vahia A, et al; Henry Ford COVID-19 Management Task Force. Early short-course corticosteroids in hos- pitalized patients with COVID-19. Clin Infect Dis. 2020;71:2114- 2120. [PMID: 32427279] doi:10.1093/cid/ciaa601</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_4HWk48Q">The effect of the timing of dexamethasone administration in patients with COVID-19 pneumonia</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.4046/trd.2021.0309</idno>
		<idno type="PMID">33779109</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ECTDKNn">Tuberc Respir Dis</title>
		<imprint>
			<date type="published" when="2021">2021</date>
			<pubPlace>Seoul)</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee HW, Park J, Lee J, et al. The effect of the timing of dexa- methasone administration in patients with COVID-19 pneumonia. Tuberc Respir Dis (Seoul). 2021. [PMID: 33779109] doi:10.4046/ trd.2021.0309</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_yZcsgbp">COVID-19 Spanish ICU Network. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Monedero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Castro</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13054-020-03422-3</idno>
		<idno type="PMID">33397463</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zhAdd3N">Crit Care</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Monedero P, Gea A, Castro P, et al; COVID-19 Spanish ICU Network. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study. Crit Care. 2021;25:2. [PMID: 33397463] doi:10.1186/s13054-020-03422-3</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_4k8q4MG">Early intervention likely improves mortality in COVID-19 infection</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Goyal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mansab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iqbal</surname></persName>
		</author>
		<idno type="DOI">10.7861/clinmed.2020-0214</idno>
		<idno type="PMID">32357975</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZSN5Yrm">Clin Med (Lond)</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="248" to="250" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goyal DK, Mansab F, Iqbal A, et al. Early intervention likely improves mortality in COVID-19 infection. Clin Med (Lond). 2020;20:248-250. [PMID: 32357975] doi:10.7861/clinmed.2020- 0214</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_RSBv4z6">Automated hovering in health care-watching over the 5000 hours</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmp1203869</idno>
		<idno type="PMID">22716935</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EjqxWvq">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="1" to="3" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Asch DA, Muller RW, Volpp KG. Automated hovering in health care-watching over the 5000 hours. N Engl J Med. 2012;367:1-3. [PMID: 22716935] doi:10.1056/NEJMp1203869</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_eyz94s7">Design of the pilot, proof of concept REMOTE-COVID trial: remote monitoring use in suspected cases of COVID-19 (SARS-CoV-2)</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Iqbal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Joshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Davies</surname></persName>
		</author>
		<idno type="DOI">10.1186/s40814-021-00804-4</idno>
		<idno type="PMID">33673868</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9D2gEZc">Pilot Feasibility Stud</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">62</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Iqbal FM, Joshi M, Davies G, et al. Design of the pilot, proof of concept REMOTE-COVID trial: remote monitoring use in suspected cases of COVID-19 (SARS-CoV-2). Pilot Feasibility Stud. 2021;7:62. [PMID: 33673868] doi:10.1186/s40814-021-00804-4</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_PWc6keZ">Novel use of home pulse oximetry monitoring in COVID-19 patients discharged from the emergency department identifies need for hospitalization</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Majmudar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stein</surname></persName>
		</author>
		<idno type="DOI">10.1111/acem.14053</idno>
		<idno type="PMID">32779828</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HdPsX8d">Acad Emerg Med</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="681" to="692" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shah S, Majmudar K, Stein A, et al. Novel use of home pulse oximetry monitoring in COVID-19 patients discharged from the emergency department identifies need for hospitalization. Acad Emerg Med. 2020;27:681-692. [PMID: 32779828] doi:10.1111/ acem.14053</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_h4kZWFN">Implementation and evaluation of a COVID-19 rapid follow-up service for patients discharged from the emergency department</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Norris-Grey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Luintel</surname></persName>
		</author>
		<idno type="DOI">10.7861/clinmed.2020-0816</idno>
		<idno type="PMID">33355255</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fgYHN7a">Clin Med (Lond)</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="57" to="e62" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bell LC, Norris-Grey C, Luintel A, et al; University College London Hospitals COVID response team. Implementation and evaluation of a COVID-19 rapid follow-up service for patients discharged from the emergency department. Clin Med (Lond). 2021;21:e57-e62. [PMID: 33355255] doi:10.7861/clinmed.2020-0816</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_mZ3ATkS">Application of telemedicine and eHealth technology for clinical services in response to COVID-19 pandemic</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Bokolo</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12553-020-00516-4</idno>
		<idno type="PMID">33469474</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hRAf5T7">Health Technol (Berl)</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="359" to="366" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bokolo AJ. Application of telemedicine and eHealth technol- ogy for clinical services in response to COVID-19 pandemic. Health Technol (Berl). 2021;11:359-366. [PMID: 33469474] doi:10.1007/ s12553-020-00516-4</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_JcnX45w">Assessment of racial/ethnic disparities in hospitalization and mortality in patients with COVID-19 in New York City</title>
		<author>
			<persName><forename type="first">G</forename><surname>Ogedegbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ravenell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Adhikari</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2020.26881</idno>
		<idno type="PMID">33275153</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TbTD3dH">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">2026881</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ogedegbe G, Ravenell J, Adhikari S, et al. Assessment of racial/eth- nic disparities in hospitalization and mortality in patients with COVID-19 in New York City. JAMA Netw Open. 2020;3:e2026881. [PMID: 33275153] doi:10.1001/jamanetworkopen.2020.26881</note>
</biblStruct>

<biblStruct xml:id="b51">
	<monogr>
		<idno type="DOI">10.1101/2022.01.04.22268760</idno>
		<ptr target="www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html" />
		<title level="m" xml:id="_NFSQGw9">Risk for COVID-19 infection, hospitalization, and death by race/ethnicity</title>
		<imprint>
			<date type="published" when="2021-04-19">19 April 2021</date>
		</imprint>
		<respStmt>
			<orgName>Centers for Disease Control and Prevention</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Centers for Disease Control and Prevention. Risk for COVID-19 infection, hospitalization, and death by race/ethnicity. Accessed at www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/ hospitalization-death-by-race-ethnicity.html on 19 April 2021.</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_eJkynQu">Hospitalization and mortality among Black patients and White patients with Covid-19</title>
		<author>
			<persName><forename type="first">Price-Haywood</forename><surname>Eg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Burton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fort</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMsa2011686</idno>
		<idno type="PMID">32459916</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_h8QfEMc">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope unit="page" from="2534" to="2543" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Price-Haywood EG, Burton J, Fort D, et al. Hospitalization and mortality among Black patients and White patients with Covid-19. N Engl J Med. 2020;382:2534-2543. [PMID: 32459916] doi:10.1056/ NEJMsa2011686</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_Cd6MczE">Characteristics, outcomes, and trends of patients with COVID-19-related critical illness at a learning health system in the United States</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Anesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jablonski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Harhay</surname></persName>
		</author>
		<idno type="DOI">10.7326/m20-5327</idno>
		<idno type="PMID">33460330</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dPPVv9w">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="page" from="613" to="621" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Anesi GL, Jablonski J, Harhay MO, et al. Characteristics, out- comes, and trends of patients with COVID-19-related critical illness at a learning health system in the United States. Ann Intern Med. 2021;174:613-621. [PMID: 33460330] doi:10.7326/M20-5327</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_wWnA2kg">Trends in COVID-19 risk-adjusted mortality rates</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Horwitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Cerfolio</surname></persName>
		</author>
		<idno type="DOI">10.12788/jhm.3552MD1124</idno>
		<idno type="PMID">33147129</idno>
		<ptr target="07/28/" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_8ruJsbg">Annals of Internal Medicine</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="90" to="92" />
			<date type="published" when="2021-02">2021. February 2022. 2025</date>
		</imprint>
	</monogr>
	<note>Find out more at Annals.org Searching for a particular Annals article? Find the articles you&apos;re looking for with Annals.org&apos;s Advanced Search: • Search by title, authors, citations, and more • Search archived articles • Save your searches • Personalize your alerts ORIGINAL RESEARCH Outcomes of Automated Home Monitoring for COVID-19 190 J Hosp Med</note>
	<note type="raw_reference">Horwitz LI, Jones SA, Cerfolio RJ, et al. Trends in COVID-19 risk-adjusted mortality rates. J Hosp Med. 2021;16:90-92. [PMID: 33147129] doi:10.12788/jhm.3552 MD1124 Find out more at Annals.org Searching for a particular Annals article? Find the articles you&apos;re looking for with Annals.org&apos;s Advanced Search: • Search by title, authors, citations, and more • Search archived articles • Save your searches • Personalize your alerts ORIGINAL RESEARCH Outcomes of Automated Home Monitoring for COVID-19 190 Annals of Internal Medicine • Vol. 175 No. 2 • February 2022 Annals.org Downloaded from https://annals.org by University of Iowa Libraries on 07/28/2025.</note>
</biblStruct>

<biblStruct xml:id="b55">
	<monogr>
		<title level="m" type="main" xml:id="_9hK5WK5">Critical revision of the article for important intellectual content</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">U</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">F</forename><surname>Meisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>O'malley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mannion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chaiyachati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">U</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Xiong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Kilaru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">F</forename><surname>Meisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Snider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chaiyachati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">U</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chaiyachati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">U</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Kilaru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Snider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chaiyachati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">U</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Xiong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Kilaru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Do</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">F</forename><surname>Meisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Snider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Parambath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Chisholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>O'malley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mannion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Huffenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcginley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Balachandran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chaiyachati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><forename type="middle">U</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chaiyachati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chaiyachati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chaiyachati</surname></persName>
		</author>
		<idno type="DOI">10.7326/m21-2019</idno>
		<editor>. Perez, D.L. Chisholm, S. Kelly</editor>
		<imprint/>
	</monogr>
	<note>Conception and design Drafting of the article Analysis and interpretation of the data Final approval of the article Provision of study materials or patients: A</note>
	<note type="raw_reference">Author Contributions: Conception and design: M.K. Delgado, A.U. Morgan, D.A. Asch, K.C. Lee, Z.F. Meisel, D. Lam, C.J. O&apos;Malley, N. Mannion, N. Khan, K.H. Chaiyachati. Analysis and interpretation of the data: M.K. Delgado, A.U. Morgan, D.A. Asch, R. Xiong, A.S. Kilaru, A.B. Friedman, Z.F. Meisel, C.K. Snider, N. Mitra, K.H. Chaiyachati. Drafting of the article: M.K. Delgado, A.U. Morgan, K.C. Lee, K. H. Chaiyachati. Critical revision of the article for important intellectual content: M.K. Delgado, A.U. Morgan, D.A. Asch, A.S. Kilaru, K.C. Lee, A. B. Friedman, C.K. Snider, N. Mitra, K.H. Chaiyachati. Final approval of the article: M.K. Delgado, A.U. Morgan, D.A. Asch, R. Xiong, A.S. Kilaru, K.C. Lee, D. Do, A.B. Friedman, Z.F. Meisel, C.K. Snider, D. Lam, A. Parambath, C. Wood, C.M. Wilson, M. Perez, D.L. Chisholm, S. Kelly, C.J. O&apos;Malley, N. Mannion, A.M. Huffenberger, S. McGinley, M. Balachandran, N. Khan, N. Mitra, K.H. Chaiyachati. Provision of study materials or patients: A.U. Morgan, K.C. Lee, M. Perez, K.H. Chaiyachati. Statistical expertise: M.K. Delgado, A.B. Friedman, N. Mitra, K. H. Chaiyachati. Obtaining of funding: M.K. Delgado, A.U. Morgan, A.S. Kilaru, Z.F. Meisel, S. Kelly, N. Mitra, K.H. Chaiyachati. Administrative, technical, or logistic support: M.K. Delgado, A. U. Morgan, A.S. Kilaru, K.C. Lee, D. Do, D. Lam, M. Perez, D.L. Chisholm, S. Kelly, C.J. O&apos;Malley, A.M. Huffenberger, S. McGinley, M. Balachandran, N. Khan, K.H. Chaiyachati. Collection and assembly of data: M.K. Delgado, A.U. Morgan, R. Xiong, K.C. Lee, D. Do, C.K. Snider, D. Lam, A. Parambath, C. Wood, D.L. Chisholm, S. Kelly, N. Mannion, A.M. Huffenberger, S. McGinley, M. Balachandran, N. Khan, K.H. Chaiyachati. Annals.org Annals of Internal Medicine • Vol. 175 No. 2 • February 2022 Downloaded from https://annals.org by of Iowa Libraries on 07/28/2025.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
